id	sid	tid	token	lemma	pos
aiua-5031	1	1	stesura	stesura	PROPN
aiua-5031	1	2	seveso	seveso	PROPN
aiua-5031	1	3	archivio	archivio	PROPN
aiua-5031	1	4	italiano	italiano	X
aiua-5031	1	5	di	di	X
aiua-5031	1	6	urologia	urologia	PROPN
aiua-5031	1	7	e	e	PROPN
aiua-5031	1	8	andrologia	andrologia	NOUN
aiua-5031	1	9	2014	2014	NUM
aiua-5031	1	10	;	;	PUNCT
aiua-5031	1	11	86	86	NUM
aiua-5031	1	12	,	,	PUNCT
aiua-5031	1	13	4288	4288	NUM
aiua-5031	1	14	original	original	ADJ
aiua-5031	1	15	paper	paper	NOUN
aiua-5031	1	16	evaluation	evaluation	NOUN
aiua-5031	1	17	of	of	ADP
aiua-5031	1	18	the	the	DET
aiua-5031	1	19	pathologic	pathologic	ADJ
aiua-5031	1	20	results	result	NOUN
aiua-5031	1	21	of	of	ADP
aiua-5031	1	22	prostate	prostate	NOUN
aiua-5031	1	23	biopsies	biopsy	NOUN
aiua-5031	1	24	in	in	ADP
aiua-5031	1	25	terms	term	NOUN
aiua-5031	1	26	of	of	ADP
aiua-5031	1	27	age	age	NOUN
aiua-5031	1	28	,	,	PUNCT
aiua-5031	1	29	gleason	gleason	PROPN
aiua-5031	1	30	score	score	NOUN
aiua-5031	1	31	and	and	CCONJ
aiua-5031	1	32	psa	psa	VERB
aiua-5031	1	33	level	level	NOUN
aiua-5031	1	34	:	:	PUNCT
aiua-5031	1	35	our	our	PRON
aiua-5031	1	36	experience	experience	NOUN
aiua-5031	1	37	and	and	CCONJ
aiua-5031	1	38	review	review	NOUN
aiua-5031	1	39	of	of	ADP
aiua-5031	1	40	the	the	DET
aiua-5031	1	41	literature	literature	NOUN
aiua-5031	1	42	selcuk	selcuk	PROPN
aiua-5031	1	43	sarıkaya	sarıkaya	PROPN
aiua-5031	1	44	1	1	NUM
aiua-5031	1	45	,	,	PUNCT
aiua-5031	1	46	mustafa	mustafa	NOUN
aiua-5031	1	47	resorlu	resorlu	ADJ
aiua-5031	1	48	2	2	NUM
aiua-5031	1	49	,	,	PUNCT
aiua-5031	1	50	ural	ural	ADJ
aiua-5031	1	51	oguz	oguz	NOUN
aiua-5031	1	52	3	3	NUM
aiua-5031	1	53	,	,	PUNCT
aiua-5031	1	54	mustafa	mustafa	PROPN
aiua-5031	1	55	yordam	yordam	PROPN
aiua-5031	1	56	1	1	NUM
aiua-5031	1	57	,	,	PUNCT
aiua-5031	1	58	omer	omer	PROPN
aiua-5031	1	59	faruk	faruk	PROPN
aiua-5031	1	60	bozkurt	bozkurt	PROPN
aiua-5031	1	61	1	1	NUM
aiua-5031	1	62	,	,	PUNCT
aiua-5031	1	63	ali	ali	PROPN
aiua-5031	1	64	unsal	unsal	PROPN
aiua-5031	1	65	1	1	NUM
aiua-5031	1	66	1	1	NUM
aiua-5031	1	67	keçioren	keçioren	NOUN
aiua-5031	1	68	training	training	NOUN
aiua-5031	1	69	and	and	CCONJ
aiua-5031	1	70	research	research	NOUN
aiua-5031	1	71	hospital	hospital	NOUN
aiua-5031	1	72	,	,	PUNCT
aiua-5031	1	73	departmant	departmant	ADJ
aiua-5031	1	74	of	of	ADP
aiua-5031	1	75	urology	urology	NOUN
aiua-5031	1	76	,	,	PUNCT
aiua-5031	1	77	ankara	ankara	PROPN
aiua-5031	1	78	,	,	PUNCT
aiua-5031	1	79	turkey	turkey	PROPN
aiua-5031	1	80	;	;	PUNCT
aiua-5031	1	81	2	2	NUM
aiua-5031	1	82	canakkale	canakkale	NOUN
aiua-5031	1	83	onsekiz	onsekiz	PROPN
aiua-5031	1	84	mart	mart	PROPN
aiua-5031	1	85	university	university	PROPN
aiua-5031	1	86	,	,	PUNCT
aiua-5031	1	87	faculty	faculty	NOUN
aiua-5031	1	88	of	of	ADP
aiua-5031	1	89	medicine	medicine	NOUN
aiua-5031	1	90	,	,	PUNCT
aiua-5031	1	91	departmant	departmant	ADJ
aiua-5031	1	92	of	of	ADP
aiua-5031	1	93	radiology	radiology	NOUN
aiua-5031	1	94	,	,	PUNCT
aiua-5031	1	95	canakkale	canakkale	PROPN
aiua-5031	1	96	,	,	PUNCT
aiua-5031	1	97	turkey	turkey	NOUN
aiua-5031	1	98	;	;	PUNCT
aiua-5031	1	99	3	3	NUM
aiua-5031	1	100	giresun	giresun	PROPN
aiua-5031	1	101	university	university	NOUN
aiua-5031	1	102	,	,	PUNCT
aiua-5031	1	103	faculty	faculty	NOUN
aiua-5031	1	104	of	of	ADP
aiua-5031	1	105	medicine	medicine	NOUN
aiua-5031	1	106	,	,	PUNCT
aiua-5031	1	107	departmant	departmant	ADJ
aiua-5031	1	108	of	of	ADP
aiua-5031	1	109	urology	urology	NOUN
aiua-5031	1	110	,	,	PUNCT
aiua-5031	1	111	giresun	giresun	NOUN
aiua-5031	1	112	,	,	PUNCT
aiua-5031	1	113	turkey	turkey	PROPN
aiua-5031	1	114	.	.	PUNCT
aiua-5031	2	1	objective	objective	NOUN
aiua-5031	2	2	:	:	PUNCT
aiua-5031	2	3	to	to	PART
aiua-5031	2	4	evaluate	evaluate	VERB
aiua-5031	2	5	the	the	DET
aiua-5031	2	6	pathologic	pathologic	ADJ
aiua-5031	2	7	and	and	CCONJ
aiua-5031	2	8	clinic	clinic	NOUN
aiua-5031	2	9	results	result	NOUN
aiua-5031	2	10	of	of	ADP
aiua-5031	2	11	our	our	PRON
aiua-5031	2	12	large	large	ADJ
aiua-5031	2	13	series	series	NOUN
aiua-5031	2	14	of	of	ADP
aiua-5031	2	15	transrectal	transrectal	ADJ
aiua-5031	2	16	prostate	prostate	NOUN
aiua-5031	2	17	biopsies	biopsy	NOUN
aiua-5031	2	18	in	in	ADP
aiua-5031	2	19	relation	relation	NOUN
aiua-5031	2	20	to	to	ADP
aiua-5031	2	21	gleason	gleason	PROPN
aiua-5031	2	22	score	score	PROPN
aiua-5031	2	23	,	,	PUNCT
aiua-5031	2	24	age	age	NOUN
aiua-5031	2	25	and	and	CCONJ
aiua-5031	2	26	psa	psa	NOUN
aiua-5031	2	27	level	level	NOUN
aiua-5031	2	28	.	.	PUNCT
aiua-5031	3	1	materials	material	NOUN
aiua-5031	3	2	and	and	CCONJ
aiua-5031	3	3	methods	method	NOUN
aiua-5031	3	4	:	:	PUNCT
aiua-5031	3	5	we	we	PRON
aiua-5031	3	6	reviewed	review	VERB
aiua-5031	3	7	the	the	DET
aiua-5031	3	8	pathologic	pathologic	ADJ
aiua-5031	3	9	results	result	NOUN
aiua-5031	3	10	of	of	ADP
aiua-5031	3	11	transrectal	transrectal	ADJ
aiua-5031	3	12	prostate	prostate	NOUN
aiua-5031	3	13	biopsies	biopsy	NOUN
aiua-5031	3	14	performed	perform	VERB
aiua-5031	3	15	because	because	SCONJ
aiua-5031	3	16	of	of	ADP
aiua-5031	3	17	high	high	ADJ
aiua-5031	3	18	psa	psa	NOUN
aiua-5031	3	19	levels	level	NOUN
aiua-5031	3	20	and	and	CCONJ
aiua-5031	3	21	abnormal	abnormal	ADJ
aiua-5031	3	22	digital	digital	ADJ
aiua-5031	3	23	rectal	rectal	ADJ
aiua-5031	3	24	examination	examination	NOUN
aiua-5031	3	25	findings	finding	NOUN
aiua-5031	3	26	between	between	ADP
aiua-5031	3	27	january	january	PROPN
aiua-5031	3	28	2008	2008	NUM
aiua-5031	3	29	and	and	CCONJ
aiua-5031	3	30	february	february	PROPN
aiua-5031	3	31	2012	2012	NUM
aiua-5031	3	32	.	.	PUNCT
aiua-5031	4	1	results	result	NOUN
aiua-5031	4	2	:	:	PUNCT
aiua-5031	4	3	the	the	DET
aiua-5031	4	4	pathologic	pathologic	ADJ
aiua-5031	4	5	result	result	NOUN
aiua-5031	4	6	of	of	ADP
aiua-5031	4	7	835	835	NUM
aiua-5031	4	8	prostate	prostate	NOUN
aiua-5031	4	9	biopsies	biopsy	NOUN
aiua-5031	4	10	was	be	AUX
aiua-5031	4	11	benign	benign	ADJ
aiua-5031	4	12	in	in	ADP
aiua-5031	4	13	82.2	82.2	NUM
aiua-5031	4	14	%	%	NOUN
aiua-5031	4	15	and	and	CCONJ
aiua-5031	4	16	malign	malign	VERB
aiua-5031	4	17	in	in	ADP
aiua-5031	4	18	17.8	17.8	NUM
aiua-5031	4	19	%	%	NOUN
aiua-5031	4	20	.	.	PUNCT
aiua-5031	5	1	furthermore	furthermore	ADV
aiua-5031	5	2	in	in	ADP
aiua-5031	5	3	3.7	3.7	NUM
aiua-5031	5	4	%	%	NOUN
aiua-5031	5	5	high	high	ADJ
aiua-5031	5	6	grade	grade	NOUN
aiua-5031	5	7	pin	pin	NOUN
aiua-5031	5	8	(	(	PUNCT
aiua-5031	5	9	prostatic	prostatic	ADJ
aiua-5031	5	10	intraepitelial	intraepitelial	ADJ
aiua-5031	5	11	neoplasia	neoplasia	NOUN
aiua-5031	5	12	)	)	PUNCT
aiua-5031	5	13	or	or	CCONJ
aiua-5031	5	14	asap	asap	INTJ
aiua-5031	5	15	(	(	PUNCT
aiua-5031	5	16	atypical	atypical	ADJ
aiua-5031	5	17	small	small	ADJ
aiua-5031	5	18	acinar	acinar	NOUN
aiua-5031	5	19	proliferation	proliferation	NOUN
aiua-5031	5	20	)	)	PUNCT
aiua-5031	5	21	was	be	AUX
aiua-5031	5	22	shown	show	VERB
aiua-5031	5	23	.	.	PUNCT
aiua-5031	6	1	in	in	ADP
aiua-5031	6	2	the	the	DET
aiua-5031	6	3	interval	interval	NOUN
aiua-5031	6	4	of	of	ADP
aiua-5031	6	5	total	total	ADJ
aiua-5031	6	6	psa	psa	NOUN
aiua-5031	6	7	values	value	NOUN
aiua-5031	6	8	between	between	ADP
aiua-5031	6	9	4	4	NUM
aiua-5031	6	10	and	and	CCONJ
aiua-5031	6	11	10	10	NUM
aiua-5031	6	12	ng	ng	PROPN
aiua-5031	6	13	/	/	SYM
aiua-5031	6	14	dl	dl	PROPN
aiua-5031	6	15	,	,	PUNCT
aiua-5031	6	16	that	that	PRON
aiua-5031	6	17	is	be	AUX
aiua-5031	6	18	thw	thw	NOUN
aiua-5031	6	19	so	so	ADV
aiua-5031	6	20	-	-	PUNCT
aiua-5031	6	21	called	call	VERB
aiua-5031	6	22	grey	grey	PROPN
aiua-5031	6	23	zone	zone	NOUN
aiua-5031	6	24	,	,	PUNCT
aiua-5031	6	25	cancer	cancer	NOUN
aiua-5031	6	26	detection	detection	NOUN
aiua-5031	6	27	rate	rate	NOUN
aiua-5031	6	28	was	be	AUX
aiua-5031	6	29	12.4	12.4	NUM
aiua-5031	6	30	%	%	NOUN
aiua-5031	6	31	.	.	PUNCT
aiua-5031	7	1	there	there	PRON
aiua-5031	7	2	was	be	VERB
aiua-5031	7	3	a	a	DET
aiua-5031	7	4	significant	significant	ADJ
aiua-5031	7	5	relationship	relationship	NOUN
aiua-5031	7	6	between	between	ADP
aiua-5031	7	7	cancer	cancer	NOUN
aiua-5031	7	8	detection	detection	NOUN
aiua-5031	7	9	and	and	CCONJ
aiua-5031	7	10	cancer	cancer	NOUN
aiua-5031	7	11	stage	stage	NOUN
aiua-5031	7	12	at	at	ADP
aiua-5031	7	13	all	all	DET
aiua-5031	7	14	high	high	ADJ
aiua-5031	7	15	levels	level	NOUN
aiua-5031	7	16	of	of	ADP
aiua-5031	7	17	psa	psa	NOUN
aiua-5031	7	18	also	also	ADV
aiua-5031	7	19	in	in	ADP
aiua-5031	7	20	the	the	DET
aiua-5031	7	21	grey	grey	PROPN
aiua-5031	7	22	zone	zone	NOUN
aiua-5031	7	23	.	.	PUNCT
aiua-5031	8	1	the	the	DET
aiua-5031	8	2	most	most	ADV
aiua-5031	8	3	common	common	ADJ
aiua-5031	8	4	gleason	gleason	PROPN
aiua-5031	8	5	score	score	NOUN
aiua-5031	8	6	observed	observe	VERB
aiua-5031	8	7	was	be	AUX
aiua-5031	8	8	3	3	NUM
aiua-5031	8	9	+	+	SYM
aiua-5031	8	10	3	3	NUM
aiua-5031	8	11	wirh	wirh	NOUN
aiua-5031	8	12	a	a	DET
aiua-5031	8	13	rate	rate	NOUN
aiua-5031	8	14	of	of	ADP
aiua-5031	8	15	7.4	7.4	NUM
aiua-5031	8	16	%	%	NOUN
aiua-5031	8	17	whereas	whereas	SCONJ
aiua-5031	8	18	the	the	DET
aiua-5031	8	19	second	second	ADJ
aiua-5031	8	20	most	most	ADV
aiua-5031	8	21	commonly	commonly	ADV
aiua-5031	8	22	observed	observe	VERB
aiua-5031	8	23	scare	scare	NOUN
aiua-5031	8	24	was	be	AUX
aiua-5031	8	25	3	3	NUM
aiua-5031	8	26	+	+	CCONJ
aiua-5031	8	27	4	4	NUM
aiua-5031	8	28	with	with	ADP
aiua-5031	8	29	a	a	DET
aiua-5031	8	30	rate	rate	NOUN
aiua-5031	8	31	of	of	ADP
aiua-5031	8	32	2.5	2.5	NUM
aiua-5031	8	33	%	%	NOUN
aiua-5031	8	34	.	.	PUNCT
aiua-5031	9	1	in	in	ADP
aiua-5031	9	2	the	the	DET
aiua-5031	9	3	patients	patient	NOUN
aiua-5031	9	4	with	with	ADP
aiua-5031	9	5	abnormal	abnormal	ADJ
aiua-5031	9	6	digital	digital	ADJ
aiua-5031	9	7	rectal	rectal	ADJ
aiua-5031	9	8	examination	examination	NOUN
aiua-5031	9	9	findings	finding	NOUN
aiua-5031	9	10	but	but	CCONJ
aiua-5031	9	11	normal	normal	ADJ
aiua-5031	9	12	psa	psa	NOUN
aiua-5031	9	13	levels	level	NOUN
aiua-5031	9	14	according	accord	VERB
aiua-5031	9	15	to	to	ADP
aiua-5031	9	16	age	age	NOUN
aiua-5031	9	17	the	the	DET
aiua-5031	9	18	cancer	cancer	NOUN
aiua-5031	9	19	detection	detection	NOUN
aiua-5031	9	20	rate	rate	NOUN
aiua-5031	9	21	was	be	AUX
aiua-5031	9	22	8.7	8.7	NUM
aiua-5031	9	23	%	%	NOUN
aiua-5031	9	24	,	,	PUNCT
aiua-5031	9	25	in	in	ADP
aiua-5031	9	26	patients	patient	NOUN
aiua-5031	9	27	with	with	ADP
aiua-5031	9	28	only	only	ADJ
aiua-5031	9	29	high	high	ADJ
aiua-5031	9	30	psa	psa	NOUN
aiua-5031	9	31	levels	level	NOUN
aiua-5031	9	32	the	the	DET
aiua-5031	9	33	rate	rate	NOUN
aiua-5031	9	34	was	be	AUX
aiua-5031	9	35	41.2	41.2	NUM
aiua-5031	9	36	%	%	NOUN
aiua-5031	9	37	and	and	CCONJ
aiua-5031	9	38	in	in	ADP
aiua-5031	9	39	the	the	DET
aiua-5031	9	40	patients	patient	NOUN
aiua-5031	9	41	with	with	ADP
aiua-5031	9	42	both	both	CCONJ
aiua-5031	9	43	high	high	ADJ
aiua-5031	9	44	psa	psa	NOUN
aiua-5031	9	45	levels	level	NOUN
aiua-5031	9	46	and	and	CCONJ
aiua-5031	9	47	abnormal	abnormal	ADJ
aiua-5031	9	48	digital	digital	ADJ
aiua-5031	9	49	rectal	rectal	ADJ
aiua-5031	9	50	examination	examination	NOUN
aiua-5031	9	51	findings	finding	NOUN
aiua-5031	9	52	.	.	PUNCT
aiua-5031	10	1	the	the	DET
aiua-5031	10	2	rate	rate	NOUN
aiua-5031	10	3	was	be	AUX
aiua-5031	10	4	49.3	49.3	NUM
aiua-5031	10	5	%	%	NOUN
aiua-5031	10	6	.	.	PUNCT
aiua-5031	11	1	conclusion	conclusion	NOUN
aiua-5031	11	2	:	:	PUNCT
aiua-5031	11	3	our	our	PRON
aiua-5031	11	4	study	study	NOUN
aiua-5031	11	5	underlines	underline	VERB
aiua-5031	11	6	the	the	DET
aiua-5031	11	7	relationship	relationship	NOUN
aiua-5031	11	8	between	between	ADP
aiua-5031	11	9	age	age	NOUN
aiua-5031	11	10	,	,	PUNCT
aiua-5031	11	11	psa	psa	NOUN
aiua-5031	11	12	level	level	NOUN
aiua-5031	11	13	and	and	CCONJ
aiua-5031	11	14	pathologic	pathologic	ADJ
aiua-5031	11	15	stage	stage	NOUN
aiua-5031	11	16	of	of	ADP
aiua-5031	11	17	prostate	prostate	NOUN
aiua-5031	11	18	cancer	cancer	NOUN
aiua-5031	11	19	and	and	CCONJ
aiua-5031	11	20	also	also	ADV
aiua-5031	11	21	the	the	DET
aiua-5031	11	22	importance	importance	NOUN
aiua-5031	11	23	of	of	ADP
aiua-5031	11	24	digital	digital	ADJ
aiua-5031	11	25	rectal	rectal	ADJ
aiua-5031	11	26	examination	examination	NOUN
aiua-5031	11	27	.	.	PUNCT
aiua-5031	12	1	key	key	ADJ
aiua-5031	12	2	words	word	NOUN
aiua-5031	12	3	:	:	PUNCT
aiua-5031	12	4	prostate	prostate	NOUN
aiua-5031	12	5	biopsy	biopsy	NOUN
aiua-5031	12	6	;	;	PUNCT
aiua-5031	12	7	gleason	gleason	PROPN
aiua-5031	12	8	score	score	NOUN
aiua-5031	12	9	;	;	PUNCT
aiua-5031	12	10	prostate	prostate	NOUN
aiua-5031	12	11	specific	specific	ADJ
aiua-5031	12	12	antigen	antigen	NOUN
aiua-5031	12	13	.	.	PUNCT
aiua-5031	12	14	submitted	submit	VERB
aiua-5031	12	15	20	20	NUM
aiua-5031	12	16	september	september	PROPN
aiua-5031	12	17	2014	2014	NUM
aiua-5031	12	18	;	;	PUNCT
aiua-5031	12	19	accepted	accept	VERB
aiua-5031	12	20	30	30	NUM
aiua-5031	12	21	november	november	PROPN
aiua-5031	12	22	2014	2014	NUM
aiua-5031	12	23	summary	summary	NOUN
aiua-5031	12	24	no	no	DET
aiua-5031	12	25	conflict	conflict	NOUN
aiua-5031	12	26	of	of	ADP
aiua-5031	12	27	interest	interest	NOUN
aiua-5031	12	28	declared	declare	VERB
aiua-5031	12	29	.	.	PUNCT
aiua-5031	13	1	diagnosis	diagnosis	NOUN
aiua-5031	13	2	of	of	ADP
aiua-5031	13	3	prostate	prostate	NOUN
aiua-5031	13	4	cancer	cancer	NOUN
aiua-5031	13	5	is	be	AUX
aiua-5031	13	6	important	important	ADJ
aiua-5031	13	7	as	as	SCONJ
aiua-5031	13	8	it	it	PRON
aiua-5031	13	9	gives	give	VERB
aiua-5031	13	10	direction	direction	NOUN
aiua-5031	13	11	to	to	ADP
aiua-5031	13	12	the	the	DET
aiua-5031	13	13	treatment	treatment	NOUN
aiua-5031	13	14	improving	improve	VERB
aiua-5031	13	15	long	long	ADJ
aiua-5031	13	16	-	-	PUNCT
aiua-5031	13	17	term	term	NOUN
aiua-5031	13	18	survival	survival	NOUN
aiua-5031	13	19	(	(	PUNCT
aiua-5031	13	20	4	4	NUM
aiua-5031	13	21	)	)	PUNCT
aiua-5031	13	22	.	.	PUNCT
aiua-5031	14	1	serum	serum	PROPN
aiua-5031	14	2	psa	psa	PROPN
aiua-5031	14	3	level	level	NOUN
aiua-5031	14	4	is	be	AUX
aiua-5031	14	5	the	the	DET
aiua-5031	14	6	most	most	ADV
aiua-5031	14	7	commonly	commonly	ADJ
aiua-5031	14	8	examination	examination	NOUN
aiua-5031	14	9	used	use	VERB
aiua-5031	14	10	to	to	PART
aiua-5031	14	11	screen	screen	VERB
aiua-5031	14	12	prostate	prostate	NOUN
aiua-5031	14	13	cancer	cancer	NOUN
aiua-5031	14	14	(	(	PUNCT
aiua-5031	14	15	5	5	NUM
aiua-5031	14	16	)	)	PUNCT
aiua-5031	14	17	.	.	PUNCT
aiua-5031	15	1	prostate	prostate	NOUN
aiua-5031	15	2	biopsy	biopsy	PROPN
aiua-5031	15	3	,	,	PUNCT
aiua-5031	15	4	is	be	AUX
aiua-5031	15	5	the	the	DET
aiua-5031	15	6	main	main	ADJ
aiua-5031	15	7	method	method	NOUN
aiua-5031	15	8	for	for	ADP
aiua-5031	15	9	the	the	DET
aiua-5031	15	10	diagnosis	diagnosis	NOUN
aiua-5031	15	11	of	of	ADP
aiua-5031	15	12	prostate	prostate	NOUN
aiua-5031	15	13	cancer	cancer	NOUN
aiua-5031	15	14	and	and	CCONJ
aiua-5031	15	15	higher	high	ADJ
aiua-5031	15	16	psa	psa	NOUN
aiua-5031	15	17	levels	level	NOUN
aiua-5031	15	18	and	and	CCONJ
aiua-5031	15	19	abnormal	abnormal	ADJ
aiua-5031	15	20	digital	digital	ADJ
aiua-5031	15	21	rectal	rectal	ADJ
aiua-5031	15	22	examination	examination	NOUN
aiua-5031	15	23	findings	finding	NOUN
aiua-5031	15	24	are	be	AUX
aiua-5031	15	25	the	the	DET
aiua-5031	15	26	indications	indication	NOUN
aiua-5031	15	27	of	of	ADP
aiua-5031	15	28	prostate	prostate	NOUN
aiua-5031	15	29	biopsy	biopsy	NOUN
aiua-5031	15	30	(	(	PUNCT
aiua-5031	15	31	4	4	NUM
aiua-5031	15	32	,	,	PUNCT
aiua-5031	15	33	6	6	NUM
aiua-5031	15	34	)	)	PUNCT
aiua-5031	15	35	.	.	PUNCT
aiua-5031	16	1	in	in	ADP
aiua-5031	16	2	the	the	DET
aiua-5031	16	3	united	united	PROPN
aiua-5031	16	4	states	states	PROPN
aiua-5031	16	5	of	of	ADP
aiua-5031	16	6	america	america	PROPN
aiua-5031	16	7	it	it	PRON
aiua-5031	16	8	is	be	AUX
aiua-5031	16	9	reported	report	VERB
aiua-5031	16	10	that	that	SCONJ
aiua-5031	16	11	over	over	ADP
aiua-5031	16	12	1	1	NUM
aiua-5031	16	13	million	million	NUM
aiua-5031	16	14	prostate	prostate	NOUN
aiua-5031	16	15	biopsies	biopsy	NOUN
aiua-5031	16	16	are	be	AUX
aiua-5031	16	17	performed	perform	VERB
aiua-5031	16	18	annually	annually	ADV
aiua-5031	16	19	(	(	PUNCT
aiua-5031	16	20	3	3	NUM
aiua-5031	16	21	)	)	PUNCT
aiua-5031	16	22	.	.	PUNCT
aiua-5031	17	1	pain	pain	NOUN
aiua-5031	17	2	,	,	PUNCT
aiua-5031	17	3	infection	infection	NOUN
aiua-5031	17	4	and	and	CCONJ
aiua-5031	17	5	hemorrage	hemorrage	NOUN
aiua-5031	17	6	are	be	AUX
aiua-5031	17	7	some	some	PRON
aiua-5031	17	8	of	of	ADP
aiua-5031	17	9	the	the	DET
aiua-5031	17	10	complications	complication	NOUN
aiua-5031	17	11	of	of	ADP
aiua-5031	17	12	transrectal	transrectal	ADJ
aiua-5031	17	13	ultrasonography	ultrasonography	NOUN
aiua-5031	17	14	guided	guide	VERB
aiua-5031	17	15	prostate	prostate	NOUN
aiua-5031	17	16	biopsy	biopsy	NOUN
aiua-5031	17	17	(	(	PUNCT
aiua-5031	17	18	6	6	NUM
aiua-5031	17	19	)	)	PUNCT
aiua-5031	17	20	.	.	PUNCT
aiua-5031	18	1	gleason	gleason	PROPN
aiua-5031	18	2	score	score	NOUN
aiua-5031	18	3	of	of	ADP
aiua-5031	18	4	prostate	prostate	NOUN
aiua-5031	18	5	cancer	cancer	NOUN
aiua-5031	18	6	is	be	AUX
aiua-5031	18	7	used	use	VERB
aiua-5031	18	8	for	for	ADP
aiua-5031	18	9	determining	determine	VERB
aiua-5031	18	10	treatment	treatment	NOUN
aiua-5031	18	11	and	and	CCONJ
aiua-5031	18	12	follow	follow	VERB
aiua-5031	18	13	-	-	PUNCT
aiua-5031	18	14	up	up	ADP
aiua-5031	18	15	modalities	modality	NOUN
aiua-5031	18	16	(	(	PUNCT
aiua-5031	18	17	7	7	NUM
aiua-5031	18	18	,	,	PUNCT
aiua-5031	18	19	8)	8)	NUM
aiua-5031	18	20	.	.	PUNCT
aiua-5031	19	1	in	in	ADP
aiua-5031	19	2	this	this	DET
aiua-5031	19	3	study	study	NOUN
aiua-5031	19	4	,	,	PUNCT
aiua-5031	19	5	we	we	PRON
aiua-5031	19	6	reviewed	review	VERB
aiua-5031	19	7	the	the	DET
aiua-5031	19	8	pathologic	pathologic	ADJ
aiua-5031	19	9	results	result	NOUN
aiua-5031	19	10	of	of	ADP
aiua-5031	19	11	prostate	prostate	NOUN
aiua-5031	19	12	biopsies	biopsy	NOUN
aiua-5031	19	13	and	and	CCONJ
aiua-5031	19	14	their	their	PRON
aiua-5031	19	15	relationships	relationship	NOUN
aiua-5031	19	16	with	with	ADP
aiua-5031	19	17	gleason	gleason	PROPN
aiua-5031	19	18	score	score	PROPN
aiua-5031	19	19	,	,	PUNCT
aiua-5031	19	20	age	age	NOUN
aiua-5031	19	21	and	and	CCONJ
aiua-5031	19	22	psa	psa	NOUN
aiua-5031	19	23	level	level	NOUN
aiua-5031	19	24	.	.	PUNCT
aiua-5031	20	1	materials	material	NOUN
aiua-5031	20	2	and	and	CCONJ
aiua-5031	20	3	methods	method	NOUN
aiua-5031	20	4	the	the	DET
aiua-5031	20	5	results	result	NOUN
aiua-5031	20	6	of	of	ADP
aiua-5031	20	7	prostate	prostate	NOUN
aiua-5031	20	8	biopsy	biopsy	NOUN
aiua-5031	20	9	performed	perform	VERB
aiua-5031	20	10	between	between	ADP
aiua-5031	20	11	january	january	PROPN
aiua-5031	20	12	2008	2008	NUM
aiua-5031	20	13	and	and	CCONJ
aiua-5031	20	14	february	february	PROPN
aiua-5031	20	15	2012	2012	NUM
aiua-5031	20	16	were	be	AUX
aiua-5031	20	17	reviewed	review	VERB
aiua-5031	20	18	retrospectively	retrospectively	ADV
aiua-5031	20	19	.	.	PUNCT
aiua-5031	21	1	the	the	DET
aiua-5031	21	2	indications	indication	NOUN
aiua-5031	21	3	to	to	PART
aiua-5031	21	4	prostate	prostate	NOUN
aiua-5031	21	5	biopsy	biopsy	NOUN
aiua-5031	21	6	were	be	AUX
aiua-5031	21	7	higher	high	ADJ
aiua-5031	21	8	psa	psa	NOUN
aiua-5031	21	9	levels	level	NOUN
aiua-5031	21	10	according	accord	VERB
aiua-5031	21	11	to	to	ADP
aiua-5031	21	12	age	age	NOUN
aiua-5031	21	13	and	and	CCONJ
aiua-5031	21	14	abnormal	abnormal	ADJ
aiua-5031	21	15	digital	digital	ADJ
aiua-5031	21	16	rectal	rectal	ADJ
aiua-5031	21	17	examination	examination	NOUN
aiua-5031	21	18	findings	finding	NOUN
aiua-5031	21	19	.	.	PUNCT
aiua-5031	22	1	in	in	ADP
aiua-5031	22	2	our	our	PRON
aiua-5031	22	3	clinic	clinic	NOUN
aiua-5031	22	4	,	,	PUNCT
aiua-5031	22	5	transrectal	transrectal	ADJ
aiua-5031	22	6	ultrasonography	ultrasonography	NOUN
aiua-5031	22	7	guided	guide	VERB
aiua-5031	22	8	prostate	prostate	NOUN
aiua-5031	22	9	biopsies	biopsy	NOUN
aiua-5031	22	10	were	be	AUX
aiua-5031	22	11	performed	perform	VERB
aiua-5031	22	12	for	for	ADP
aiua-5031	22	13	the	the	DET
aiua-5031	22	14	patients	patient	NOUN
aiua-5031	22	15	under	under	ADP
aiua-5031	22	16	the	the	DET
aiua-5031	22	17	age	age	NOUN
aiua-5031	22	18	of	of	ADP
aiua-5031	22	19	50	50	NUM
aiua-5031	22	20	whewn	whewn	NOUN
aiua-5031	22	21	psa	psa	NOUN
aiua-5031	22	22	level	level	NOUN
aiua-5031	22	23	was	be	AUX
aiua-5031	22	24	over	over	ADP
aiua-5031	22	25	2.5	2.5	NUM
aiua-5031	22	26	ng	ng	PROPN
aiua-5031	22	27	/	/	SYM
aiua-5031	22	28	dl	dl	PROPN
aiua-5031	22	29	,	,	PUNCT
aiua-5031	22	30	for	for	ADP
aiua-5031	22	31	the	the	DET
aiua-5031	22	32	patients	patient	NOUN
aiua-5031	22	33	with	with	ADP
aiua-5031	22	34	age	age	NOUN
aiua-5031	22	35	between	between	ADP
aiua-5031	22	36	50	50	NUM
aiua-5031	22	37	and	and	CCONJ
aiua-5031	22	38	60	60	NUM
aiua-5031	22	39	when	when	SCONJ
aiua-5031	22	40	psa	psa	NOUN
aiua-5031	22	41	was	be	AUX
aiua-5031	22	42	over	over	ADP
aiua-5031	22	43	3.5	3.5	NUM
aiua-5031	22	44	ng	ng	PROPN
aiua-5031	22	45	/	/	SYM
aiua-5031	22	46	dl	dl	PROPN
aiua-5031	22	47	and	and	CCONJ
aiua-5031	22	48	for	for	ADP
aiua-5031	22	49	the	the	DET
aiua-5031	22	50	patients	patient	NOUN
aiua-5031	22	51	over	over	ADP
aiua-5031	22	52	the	the	DET
aiua-5031	22	53	age	age	NOUN
aiua-5031	22	54	of	of	ADP
aiua-5031	22	55	60	60	NUM
aiua-5031	22	56	when	when	SCONJ
aiua-5031	22	57	psa	psa	NOUN
aiua-5031	22	58	level	level	NOUN
aiua-5031	22	59	was	be	AUX
aiua-5031	22	60	over	over	ADP
aiua-5031	22	61	4	4	NUM
aiua-5031	22	62	ng	ng	PROPN
aiua-5031	22	63	/	/	SYM
aiua-5031	22	64	dl	dl	PROPN
aiua-5031	22	65	.	.	PROPN
aiua-5031	22	66	biopsies	biopsy	NOUN
aiua-5031	22	67	were	be	AUX
aiua-5031	22	68	also	also	ADV
aiua-5031	22	69	performed	perform	VERB
aiua-5031	22	70	for	for	ADP
aiua-5031	22	71	the	the	DET
aiua-5031	22	72	patients	patient	NOUN
aiua-5031	22	73	with	with	ADP
aiua-5031	22	74	abnormal	abnormal	ADJ
aiua-5031	22	75	digital	digital	ADJ
aiua-5031	22	76	rectal	rectal	ADJ
aiua-5031	22	77	examination	examination	NOUN
aiua-5031	22	78	findings	finding	NOUN
aiua-5031	22	79	regardless	regardless	ADV
aiua-5031	22	80	of	of	ADP
aiua-5031	22	81	psa	psa	NOUN
aiua-5031	22	82	level	level	NOUN
aiua-5031	22	83	.	.	PUNCT
aiua-5031	23	1	after	after	ADP
aiua-5031	23	2	digital	digital	ADJ
aiua-5031	23	3	rectal	rectal	ADJ
aiua-5031	23	4	examination	examination	NOUN
aiua-5031	23	5	,	,	PUNCT
aiua-5031	23	6	biopsies	biopsy	NOUN
aiua-5031	23	7	were	be	AUX
aiua-5031	23	8	performed	perform	VERB
aiua-5031	23	9	in	in	ADP
aiua-5031	23	10	the	the	DET
aiua-5031	23	11	left	left	ADJ
aiua-5031	23	12	lateral	lateral	ADJ
aiua-5031	23	13	decubitus	decubitus	NOUN
aiua-5031	23	14	position	position	NOUN
aiua-5031	23	15	.	.	PUNCT
aiua-5031	24	1	four	four	NUM
aiua-5031	24	2	ml	ml	NOUN
aiua-5031	24	3	lidocaine	lidocaine	NOUN
aiua-5031	24	4	(	(	PUNCT
aiua-5031	24	5	2	2	NUM
aiua-5031	24	6	%	%	NOUN
aiua-5031	24	7	)	)	PUNCT
aiua-5031	24	8	or	or	CCONJ
aiua-5031	24	9	prilocaine	prilocaine	NOUN
aiua-5031	24	10	(	(	PUNCT
aiua-5031	24	11	2	2	NUM
aiua-5031	24	12	%	%	NOUN
aiua-5031	24	13	)	)	PUNCT
aiua-5031	24	14	were	be	AUX
aiua-5031	24	15	used	use	VERB
aiua-5031	24	16	for	for	ADP
aiua-5031	24	17	local	local	ADJ
aiua-5031	24	18	anesthesia	anesthesia	NOUN
aiua-5031	24	19	.	.	PUNCT
aiua-5031	25	1	diposable	diposable	ADJ
aiua-5031	25	2	or	or	CCONJ
aiua-5031	25	3	re	re	ADJ
aiua-5031	25	4	-	-	ADJ
aiua-5031	25	5	usable	usable	ADJ
aiua-5031	25	6	guides	guide	NOUN
aiua-5031	25	7	and	and	CCONJ
aiua-5031	25	8	18	18	NUM
aiua-5031	25	9	-	-	PUNCT
aiua-5031	25	10	gauge	gauge	NOUN
aiua-5031	25	11	biopsy	biopsy	NOUN
aiua-5031	25	12	needles	needle	NOUN
aiua-5031	25	13	were	be	AUX
aiua-5031	25	14	used	use	VERB
aiua-5031	25	15	for	for	ADP
aiua-5031	25	16	the	the	DET
aiua-5031	25	17	biopsies	biopsy	NOUN
aiua-5031	25	18	.	.	PUNCT
aiua-5031	26	1	biopsies	biopsy	NOUN
aiua-5031	26	2	were	be	AUX
aiua-5031	26	3	performed	perform	VERB
aiua-5031	26	4	taking	take	VERB
aiua-5031	26	5	12	12	NUM
aiua-5031	26	6	cores	core	NOUN
aiua-5031	26	7	(	(	PUNCT
aiua-5031	26	8	6	6	NUM
aiua-5031	26	9	for	for	ADP
aiua-5031	26	10	right	right	ADJ
aiua-5031	26	11	lobe	lobe	NOUN
aiua-5031	26	12	,	,	PUNCT
aiua-5031	26	13	6	6	NUM
aiua-5031	26	14	for	for	ADP
aiua-5031	26	15	left	left	ADJ
aiua-5031	26	16	lobe	lobe	NOUN
aiua-5031	26	17	)	)	PUNCT
aiua-5031	26	18	.	.	PUNCT
aiua-5031	27	1	detailed	detailed	ADJ
aiua-5031	27	2	consent	consent	NOUN
aiua-5031	27	3	forms	form	NOUN
aiua-5031	27	4	were	be	AUX
aiua-5031	27	5	obtained	obtain	VERB
aiua-5031	27	6	from	from	ADP
aiua-5031	27	7	the	the	DET
aiua-5031	27	8	patients	patient	NOUN
aiua-5031	27	9	who	who	PRON
aiua-5031	27	10	were	be	AUX
aiua-5031	27	11	given	give	VERB
aiua-5031	27	12	detailed	detailed	ADJ
aiua-5031	27	13	information	information	NOUN
aiua-5031	27	14	before	before	ADP
aiua-5031	27	15	the	the	DET
aiua-5031	27	16	biopsy	biopsy	NOUN
aiua-5031	27	17	procedure	procedure	NOUN
aiua-5031	27	18	.	.	PUNCT
aiua-5031	28	1	after	after	SCONJ
aiua-5031	28	2	the	the	DET
aiua-5031	28	3	procedure	procedure	NOUN
aiua-5031	28	4	the	the	DET
aiua-5031	28	5	patients	patient	NOUN
aiua-5031	28	6	were	be	AUX
aiua-5031	28	7	directed	direct	VERB
aiua-5031	28	8	to	to	ADP
aiua-5031	28	9	the	the	DET
aiua-5031	28	10	uro	uro	NOUN
aiua-5031	28	11	-	-	PUNCT
aiua-5031	28	12	oncology	oncology	NOUN
aiua-5031	28	13	polyclinic	polyclinic	ADJ
aiua-5031	28	14	with	with	ADP
aiua-5031	28	15	the	the	DET
aiua-5031	28	16	results	result	NOUN
aiua-5031	28	17	of	of	ADP
aiua-5031	28	18	biopsies	biopsy	NOUN
aiua-5031	28	19	and	and	CCONJ
aiua-5031	28	20	treatment	treatment	NOUN
aiua-5031	28	21	modalities	modality	NOUN
aiua-5031	28	22	were	be	AUX
aiua-5031	28	23	decided	decide	VERB
aiua-5031	28	24	according	accord	VERB
aiua-5031	28	25	to	to	ADP
aiua-5031	28	26	the	the	DET
aiua-5031	28	27	results	result	NOUN
aiua-5031	28	28	.	.	PUNCT
aiua-5031	29	1	doi	doi	NOUN
aiua-5031	29	2	:	:	PUNCT
aiua-5031	29	3	10.4081	10.4081	NUM
aiua-5031	29	4	/	/	SYM
aiua-5031	29	5	aiua.2014.4.288	aiua.2014.4.288	ADJ
aiua-5031	29	6	introduction	introduction	NOUN
aiua-5031	29	7	prostate	prostate	NOUN
aiua-5031	29	8	cancer	cancer	NOUN
aiua-5031	29	9	,	,	PUNCT
aiua-5031	29	10	is	be	AUX
aiua-5031	29	11	the	the	DET
aiua-5031	29	12	most	most	ADV
aiua-5031	29	13	common	common	ADJ
aiua-5031	29	14	cancer	cancer	NOUN
aiua-5031	29	15	observed	observe	VERB
aiua-5031	29	16	in	in	ADP
aiua-5031	29	17	men	man	NOUN
aiua-5031	29	18	and	and	CCONJ
aiua-5031	29	19	when	when	SCONJ
aiua-5031	29	20	deaths	death	NOUN
aiua-5031	29	21	due	due	ADP
aiua-5031	29	22	to	to	ADP
aiua-5031	29	23	cancer	cancer	NOUN
aiua-5031	29	24	are	be	AUX
aiua-5031	29	25	considered	consider	VERB
aiua-5031	29	26	,	,	PUNCT
aiua-5031	29	27	prostate	prostate	NOUN
aiua-5031	29	28	cancer	cancer	NOUN
aiua-5031	29	29	ranks	rank	VERB
aiua-5031	29	30	second	second	ADV
aiua-5031	29	31	after	after	ADP
aiua-5031	29	32	the	the	DET
aiua-5031	29	33	lung	lung	NOUN
aiua-5031	29	34	cancer	cancer	NOUN
aiua-5031	29	35	(	(	PUNCT
aiua-5031	29	36	1	1	NUM
aiua-5031	29	37	,	,	PUNCT
aiua-5031	29	38	2	2	NUM
aiua-5031	29	39	)	)	PUNCT
aiua-5031	29	40	.	.	PUNCT
aiua-5031	30	1	in	in	ADP
aiua-5031	30	2	2008	2008	NUM
aiua-5031	30	3	,	,	PUNCT
aiua-5031	30	4	340.000	340.000	NUM
aiua-5031	30	5	patients	patient	NOUN
aiua-5031	30	6	were	be	AUX
aiua-5031	30	7	diagnosed	diagnose	VERB
aiua-5031	30	8	with	with	ADP
aiua-5031	30	9	prostate	prostate	NOUN
aiua-5031	30	10	cancer	cancer	NOUN
aiua-5031	30	11	and	and	CCONJ
aiua-5031	30	12	over	over	ADP
aiua-5031	30	13	70.000	70.000	NUM
aiua-5031	30	14	deaths	death	NOUN
aiua-5031	30	15	were	be	AUX
aiua-5031	30	16	reported	report	VERB
aiua-5031	30	17	due	due	ADP
aiua-5031	30	18	to	to	ADP
aiua-5031	30	19	prostate	prostate	NOUN
aiua-5031	30	20	cancer	cancer	NOUN
aiua-5031	30	21	in	in	ADP
aiua-5031	30	22	european	european	PROPN
aiua-5031	30	23	union	union	PROPN
aiua-5031	30	24	countries	country	NOUN
aiua-5031	30	25	(	(	PUNCT
aiua-5031	30	26	3	3	NUM
aiua-5031	30	27	)	)	PUNCT
aiua-5031	30	28	.	.	PUNCT
aiua-5031	31	1	early	early	ADJ
aiua-5031	31	2	sarikaya_stesura	sarikaya_stesura	PROPN
aiua-5031	31	3	seveso	seveso	NOUN
aiua-5031	31	4	22/01/15	22/01/15	PROPN
aiua-5031	31	5	10:01	10:01	NUM
aiua-5031	31	6	pagina	pagina	NOUN
aiua-5031	31	7	288	288	NUM
aiua-5031	31	8	289archivio	289archivio	PROPN
aiua-5031	31	9	italiano	italiano	NOUN
aiua-5031	31	10	di	di	NOUN
aiua-5031	31	11	urologia	urologia	PROPN
aiua-5031	31	12	e	e	PROPN
aiua-5031	31	13	andrologia	andrologia	NOUN
aiua-5031	31	14	2014	2014	NUM
aiua-5031	31	15	;	;	PUNCT
aiua-5031	31	16	86	86	NUM
aiua-5031	31	17	,	,	PUNCT
aiua-5031	31	18	4	4	NUM
aiua-5031	31	19	evaluation	evaluation	NOUN
aiua-5031	31	20	of	of	ADP
aiua-5031	31	21	the	the	DET
aiua-5031	31	22	pathologic	pathologic	ADJ
aiua-5031	31	23	results	result	NOUN
aiua-5031	31	24	of	of	ADP
aiua-5031	31	25	prostate	prostate	NOUN
aiua-5031	31	26	biopsies	biopsy	NOUN
aiua-5031	31	27	in	in	ADP
aiua-5031	31	28	terms	term	NOUN
aiua-5031	31	29	of	of	ADP
aiua-5031	31	30	age	age	NOUN
aiua-5031	31	31	,	,	PUNCT
aiua-5031	31	32	gleason	gleason	PROPN
aiua-5031	31	33	score	score	NOUN
aiua-5031	31	34	and	and	CCONJ
aiua-5031	31	35	psa	psa	VERB
aiua-5031	31	36	level	level	NOUN
aiua-5031	31	37	:	:	PUNCT
aiua-5031	31	38	our	our	PRON
aiua-5031	31	39	experience	experience	NOUN
aiua-5031	31	40	and	and	CCONJ
aiua-5031	31	41	review	review	NOUN
aiua-5031	31	42	of	of	ADP
aiua-5031	31	43	the	the	DET
aiua-5031	31	44	literature	literature	NOUN
aiua-5031	31	45	results	result	VERB
aiua-5031	31	46	the	the	DET
aiua-5031	31	47	results	result	NOUN
aiua-5031	31	48	of	of	ADP
aiua-5031	31	49	835	835	NUM
aiua-5031	31	50	prostate	prostate	NOUN
aiua-5031	31	51	biopsies	biopsy	NOUN
aiua-5031	31	52	showed	show	VERB
aiua-5031	31	53	656	656	NUM
aiua-5031	31	54	benign	benign	ADJ
aiua-5031	31	55	findings	finding	NOUN
aiua-5031	31	56	(	(	PUNCT
aiua-5031	31	57	78.5	78.5	NUM
aiua-5031	31	58	%	%	NOUN
aiua-5031	31	59	)	)	PUNCT
aiua-5031	31	60	,	,	PUNCT
aiua-5031	31	61	4	4	NUM
aiua-5031	31	62	gleason	gleason	NOUN
aiua-5031	31	63	2	2	NUM
aiua-5031	31	64	+	+	NOUN
aiua-5031	31	65	3	3	NUM
aiua-5031	31	66	adenocarcinomas	adenocarcinoma	NOUN
aiua-5031	31	67	(	(	PUNCT
aiua-5031	31	68	adenoca	adenoca	NOUN
aiua-5031	31	69	)	)	PUNCT
aiua-5031	31	70	(	(	PUNCT
aiua-5031	31	71	0.5	0.5	NUM
aiua-5031	31	72	%	%	NOUN
aiua-5031	31	73	)	)	PUNCT
aiua-5031	31	74	,	,	PUNCT
aiua-5031	31	75	1	1	NUM
aiua-5031	31	76	gleason	gleason	NOUN
aiua-5031	31	77	3	3	NUM
aiua-5031	31	78	+	+	SYM
aiua-5031	31	79	2	2	NUM
aiua-5031	31	80	adenoca	adenoca	NOUN
aiua-5031	31	81	(	(	PUNCT
aiua-5031	31	82	0.1	0.1	NUM
aiua-5031	31	83	%	%	NOUN
aiua-5031	31	84	)	)	PUNCT
aiua-5031	31	85	,	,	PUNCT
aiua-5031	31	86	61	61	NUM
aiua-5031	31	87	gleason	gleason	NOUN
aiua-5031	31	88	3	3	NUM
aiua-5031	31	89	+	+	SYM
aiua-5031	31	90	3	3	NUM
aiua-5031	31	91	adenoca	adenoca	NOUN
aiua-5031	31	92	(	(	PUNCT
aiua-5031	31	93	7.4	7.4	NUM
aiua-5031	31	94	%	%	NOUN
aiua-5031	31	95	)	)	PUNCT
aiua-5031	31	96	,	,	PUNCT
aiua-5031	31	97	21	21	NUM
aiua-5031	31	98	gleason	gleason	NOUN
aiua-5031	31	99	3	3	NUM
aiua-5031	31	100	+	+	SYM
aiua-5031	31	101	4	4	NUM
aiua-5031	31	102	adenoca	adenoca	NOUN
aiua-5031	31	103	(	(	PUNCT
aiua-5031	31	104	2.5	2.5	NUM
aiua-5031	31	105	%	%	NOUN
aiua-5031	31	106	)	)	PUNCT
aiua-5031	31	107	,	,	PUNCT
aiua-5031	31	108	14	14	NUM
aiua-5031	31	109	gleason	gleason	NOUN
aiua-5031	31	110	4	4	NUM
aiua-5031	31	111	+	+	SYM
aiua-5031	31	112	3	3	NUM
aiua-5031	31	113	adenoca	adenoca	NOUN
aiua-5031	31	114	(	(	PUNCT
aiua-5031	31	115	1.7	1.7	NUM
aiua-5031	31	116	%	%	NOUN
aiua-5031	31	117	)	)	PUNCT
aiua-5031	31	118	,	,	PUNCT
aiua-5031	31	119	16	16	NUM
aiua-5031	31	120	gleason	gleason	NOUN
aiua-5031	31	121	4	4	NUM
aiua-5031	31	122	+	+	SYM
aiua-5031	31	123	4	4	NUM
aiua-5031	31	124	adenoca	adenoca	NOUN
aiua-5031	31	125	(	(	PUNCT
aiua-5031	31	126	1.9	1.9	NUM
aiua-5031	31	127	%	%	NOUN
aiua-5031	31	128	)	)	PUNCT
aiua-5031	31	129	,	,	PUNCT
aiua-5031	31	130	1	1	NUM
aiua-5031	31	131	gleason	gleason	NOUN
aiua-5031	31	132	5	5	NUM
aiua-5031	31	133	+	+	SYM
aiua-5031	31	134	3	3	NUM
aiua-5031	31	135	adenoca	adenoca	NOUN
aiua-5031	31	136	(	(	PUNCT
aiua-5031	31	137	0.1	0.1	NUM
aiua-5031	31	138	%	%	NOUN
aiua-5031	31	139	)	)	PUNCT
aiua-5031	31	140	,	,	PUNCT
aiua-5031	31	141	20	20	NUM
aiua-5031	31	142	gleason	gleason	NOUN
aiua-5031	31	143	4	4	NUM
aiua-5031	31	144	+	+	SYM
aiua-5031	31	145	5	5	NUM
aiua-5031	31	146	adenoca	adenoca	NOUN
aiua-5031	31	147	(	(	PUNCT
aiua-5031	31	148	2.5	2.5	NUM
aiua-5031	31	149	%	%	NOUN
aiua-5031	31	150	)	)	PUNCT
aiua-5031	31	151	,	,	PUNCT
aiua-5031	31	152	6	6	NUM
aiua-5031	31	153	gleason	gleason	NOUN
aiua-5031	31	154	5	5	NUM
aiua-5031	31	155	+	+	SYM
aiua-5031	31	156	4	4	NUM
aiua-5031	31	157	adenoca	adenoca	NOUN
aiua-5031	31	158	(	(	PUNCT
aiua-5031	31	159	0.7	0.7	NUM
aiua-5031	31	160	%	%	NOUN
aiua-5031	31	161	)	)	PUNCT
aiua-5031	31	162	and	and	CCONJ
aiua-5031	31	163	4	4	NUM
aiua-5031	31	164	gleason	gleason	NOUN
aiua-5031	31	165	5	5	NUM
aiua-5031	31	166	+	+	SYM
aiua-5031	31	167	5	5	NUM
aiua-5031	31	168	adenoca	adenoca	NOUN
aiua-5031	31	169	(	(	PUNCT
aiua-5031	31	170	0.4	0.4	NUM
aiua-5031	31	171	%	%	NOUN
aiua-5031	31	172	)	)	PUNCT
aiua-5031	31	173	.	.	PUNCT
aiua-5031	32	1	finally	finally	ADV
aiua-5031	32	2	high	high	ADJ
aiua-5031	32	3	grade	grade	NOUN
aiua-5031	32	4	pin	pin	NOUN
aiua-5031	32	5	or	or	CCONJ
aiua-5031	32	6	asap	asap	NOUN
aiua-5031	32	7	were	be	AUX
aiua-5031	32	8	reported	report	VERB
aiua-5031	32	9	in	in	ADP
aiua-5031	32	10	31	31	NUM
aiua-5031	32	11	patients	patient	NOUN
aiua-5031	32	12	(	(	PUNCT
aiua-5031	32	13	3.7	3.7	NUM
aiua-5031	32	14	%	%	NOUN
aiua-5031	32	15	)	)	PUNCT
aiua-5031	32	16	(	(	PUNCT
aiua-5031	32	17	table	table	NOUN
aiua-5031	32	18	1	1	NUM
aiua-5031	32	19	)	)	PUNCT
aiua-5031	32	20	.	.	PUNCT
aiua-5031	33	1	prostate	prostate	NOUN
aiua-5031	33	2	cancer	cancer	NOUN
aiua-5031	33	3	detection	detection	NOUN
aiua-5031	33	4	rate	rate	NOUN
aiua-5031	33	5	was	be	AUX
aiua-5031	33	6	17.8	17.8	NUM
aiua-5031	33	7	%	%	NOUN
aiua-5031	33	8	in	in	ADP
aiua-5031	33	9	our	our	PRON
aiua-5031	33	10	prostate	prostate	NOUN
aiua-5031	33	11	biopsy	biopsy	NOUN
aiua-5031	33	12	series	series	NOUN
aiua-5031	33	13	.	.	PUNCT
aiua-5031	34	1	there	there	PRON
aiua-5031	34	2	was	be	VERB
aiua-5031	34	3	a	a	DET
aiua-5031	34	4	significant	significant	ADJ
aiua-5031	34	5	relationship	relationship	NOUN
aiua-5031	34	6	between	between	ADP
aiua-5031	34	7	higher	high	ADJ
aiua-5031	34	8	psa	psa	NOUN
aiua-5031	34	9	levels	level	NOUN
aiua-5031	34	10	and	and	CCONJ
aiua-5031	34	11	cancer	cancer	NOUN
aiua-5031	34	12	detection	detection	NOUN
aiua-5031	34	13	and	and	CCONJ
aiua-5031	34	14	cancer	cancer	NOUN
aiua-5031	34	15	stage	stage	NOUN
aiua-5031	34	16	in	in	ADP
aiua-5031	34	17	the	the	DET
aiua-5031	34	18	interval	interval	NOUN
aiua-5031	34	19	of	of	ADP
aiua-5031	34	20	total	total	ADJ
aiua-5031	34	21	psa	psa	NOUN
aiua-5031	34	22	values	value	NOUN
aiua-5031	34	23	between	between	ADP
aiua-5031	34	24	4	4	NUM
aiua-5031	34	25	and	and	CCONJ
aiua-5031	34	26	10	10	NUM
aiua-5031	34	27	ng	ng	PROPN
aiua-5031	34	28	/	/	SYM
aiua-5031	34	29	dl	dl	PROPN
aiua-5031	34	30	,	,	PUNCT
aiua-5031	34	31	that	that	PRON
aiua-5031	34	32	is	be	AUX
aiua-5031	34	33	the	the	DET
aiua-5031	34	34	so	so	ADV
aiua-5031	34	35	-	-	PUNCT
aiua-5031	34	36	called	call	VERB
aiua-5031	34	37	grey	grey	PROPN
aiua-5031	34	38	zone	zone	NOUN
aiua-5031	34	39	,	,	PUNCT
aiua-5031	34	40	cancer	cancer	NOUN
aiua-5031	34	41	detection	detection	NOUN
aiua-5031	34	42	rate	rate	NOUN
aiua-5031	34	43	was	be	AUX
aiua-5031	34	44	12.4	12.4	NUM
aiua-5031	34	45	%	%	NOUN
aiua-5031	34	46	.	.	PUNCT
aiua-5031	35	1	when	when	SCONJ
aiua-5031	35	2	the	the	DET
aiua-5031	35	3	pathologic	pathologic	ADJ
aiua-5031	35	4	results	result	NOUN
aiua-5031	35	5	were	be	AUX
aiua-5031	35	6	revie	revie	ADJ
aiua-5031	35	7	we	we	PRON
aiua-5031	35	8	d	d	PROPN
aiua-5031	35	9	by	by	ADP
aiua-5031	35	10	the	the	DET
aiua-5031	35	11	range	range	NOUN
aiua-5031	35	12	of	of	ADP
aiua-5031	35	13	serum	serum	NOUN
aiua-5031	35	14	psa	psa	NOUN
aiua-5031	35	15	levels	level	NOUN
aiua-5031	35	16	,	,	PUNCT
aiua-5031	35	17	in	in	ADP
aiua-5031	35	18	patients	patient	NOUN
aiua-5031	35	19	with	with	ADP
aiua-5031	35	20	benign	benign	ADJ
aiua-5031	35	21	prostatic	prostatic	ADJ
aiua-5031	35	22	hyperplasia	hyperplasia	NOUN
aiua-5031	35	23	(	(	PUNCT
aiua-5031	35	24	bph	bph	NOUN
aiua-5031	35	25	)	)	PUNCT
aiua-5031	35	26	psa	psa	NOUN
aiua-5031	35	27	level	level	NOUN
aiua-5031	35	28	was	be	AUX
aiua-5031	35	29	<	<	X
aiua-5031	35	30	4	4	NUM
aiua-5031	35	31	ng	ng	PROPN
aiua-5031	35	32	/	/	SYM
aiua-5031	35	33	dl	dl	PROPN
aiua-5031	35	34	in	in	ADP
aiua-5031	35	35	9.3	9.3	NUM
aiua-5031	35	36	%	%	NOUN
aiua-5031	35	37	,	,	PUNCT
aiua-5031	35	38	4	4	NUM
aiua-5031	35	39	-	-	SYM
aiua-5031	35	40	10	10	NUM
aiua-5031	35	41	ng	ng	PROPN
aiua-5031	35	42	/	/	SYM
aiua-5031	35	43	ml	ml	NOUN
aiua-5031	35	44	in	in	ADP
aiua-5031	35	45	66.8	66.8	NUM
aiua-5031	35	46	%	%	NOUN
aiua-5031	35	47	and	and	CCONJ
aiua-5031	35	48	>	>	X
aiua-5031	35	49	10	10	NUM
aiua-5031	35	50	ng	ng	PROPN
aiua-5031	35	51	/	/	SYM
aiua-5031	35	52	dl	dl	PROPN
aiua-5031	35	53	in	in	ADP
aiua-5031	35	54	23.9	23.9	NUM
aiua-5031	35	55	%	%	NOUN
aiua-5031	35	56	of	of	ADP
aiua-5031	35	57	the	the	DET
aiua-5031	35	58	patients	patient	NOUN
aiua-5031	35	59	whereas	whereas	SCONJ
aiua-5031	35	60	in	in	ADP
aiua-5031	35	61	patients	patient	NOUN
aiua-5031	35	62	with	with	ADP
aiua-5031	35	63	adenocarcinoma	adenocarcinoma	NOUN
aiua-5031	35	64	psa	psa	NOUN
aiua-5031	35	65	level	level	NOUN
aiua-5031	35	66	was	be	AUX
aiua-5031	35	67	<	<	X
aiua-5031	35	68	4	4	NUM
aiua-5031	35	69	ng	ng	PROPN
aiua-5031	35	70	/	/	SYM
aiua-5031	35	71	dl	dl	PROPN
aiua-5031	35	72	in	in	ADP
aiua-5031	35	73	4	4	NUM
aiua-5031	35	74	%	%	NOUN
aiua-5031	35	75	,	,	PUNCT
aiua-5031	35	76	4	4	NUM
aiua-5031	35	77	-	-	SYM
aiua-5031	35	78	10	10	NUM
aiua-5031	35	79	ng	ng	PROPN
aiua-5031	35	80	/	/	SYM
aiua-5031	35	81	dl	dl	PROPN
aiua-5031	35	82	in	in	ADP
aiua-5031	35	83	49.3	49.3	NUM
aiua-5031	35	84	%	%	NOUN
aiua-5031	35	85	and	and	CCONJ
aiua-5031	35	86	>	>	X
aiua-5031	35	87	10	10	NUM
aiua-5031	35	88	ng	ng	PROPN
aiua-5031	35	89	/	/	SYM
aiua-5031	35	90	dl	dl	PROPN
aiua-5031	35	91	.	.	PROPN
aiua-5031	35	92	in	in	ADP
aiua-5031	35	93	52	52	NUM
aiua-5031	35	94	%	%	NOUN
aiua-5031	35	95	.	.	PUNCT
aiua-5031	36	1	when	when	SCONJ
aiua-5031	36	2	pathologic	pathologic	ADJ
aiua-5031	36	3	data	datum	NOUN
aiua-5031	36	4	of	of	ADP
aiua-5031	36	5	the	the	DET
aiua-5031	36	6	patients	patient	NOUN
aiua-5031	36	7	with	with	ADP
aiua-5031	36	8	adenocarcinoma	adenocarcinoma	NOUN
aiua-5031	36	9	were	be	AUX
aiua-5031	36	10	examined	examine	VERB
aiua-5031	36	11	,	,	PUNCT
aiua-5031	36	12	gleason	gleason	PROPN
aiua-5031	36	13	score	score	NOUN
aiua-5031	36	14	was	be	AUX
aiua-5031	36	15	higher	high	ADJ
aiua-5031	36	16	than	than	ADP
aiua-5031	36	17	7	7	NUM
aiua-5031	36	18	in	in	ADP
aiua-5031	36	19	33	33	NUM
aiua-5031	36	20	%	%	NOUN
aiua-5031	36	21	of	of	ADP
aiua-5031	36	22	the	the	DET
aiua-5031	36	23	patients	patient	NOUN
aiua-5031	36	24	with	with	ADP
aiua-5031	36	25	psa	psa	NOUN
aiua-5031	36	26	level	level	NOUN
aiua-5031	36	27	<	<	X
aiua-5031	36	28	4	4	NUM
aiua-5031	36	29	ng	ng	PROPN
aiua-5031	36	30	/	/	SYM
aiua-5031	36	31	dl	dl	PROPN
aiua-5031	36	32	,	,	PUNCT
aiua-5031	36	33	in	in	ADP
aiua-5031	36	34	13.8	13.8	NUM
aiua-5031	36	35	%	%	NOUN
aiua-5031	36	36	of	of	ADP
aiua-5031	36	37	the	the	DET
aiua-5031	36	38	patients	patient	NOUN
aiua-5031	36	39	with	with	ADP
aiua-5031	36	40	psa	psa	NOUN
aiua-5031	36	41	level	level	NOUN
aiua-5031	36	42	4	4	NUM
aiua-5031	36	43	-	-	SYM
aiua-5031	36	44	10	10	NUM
aiua-5031	36	45	ng	ng	PROPN
aiua-5031	36	46	/	/	SYM
aiua-5031	36	47	dl	dl	PROPN
aiua-5031	36	48	and	and	CCONJ
aiua-5031	36	49	in	in	ADP
aiua-5031	36	50	46.7	46.7	NUM
aiua-5031	36	51	%	%	NOUN
aiua-5031	36	52	of	of	ADP
aiua-5031	36	53	the	the	DET
aiua-5031	36	54	patients	patient	NOUN
aiua-5031	36	55	with	with	ADP
aiua-5031	36	56	psa	psa	NOUN
aiua-5031	36	57	level	level	NOUN
aiua-5031	36	58	>	>	X
aiua-5031	36	59	10	10	NUM
aiua-5031	36	60	ng	ng	PROPN
aiua-5031	36	61	/	/	SYM
aiua-5031	36	62	dl	dl	PROPN
aiua-5031	36	63	(	(	PUNCT
aiua-5031	36	64	table	table	NOUN
aiua-5031	36	65	2	2	NUM
aiua-5031	36	66	)	)	PUNCT
aiua-5031	36	67	.	.	PUNCT
aiua-5031	37	1	when	when	SCONJ
aiua-5031	37	2	the	the	DET
aiua-5031	37	3	digital	digital	ADJ
aiua-5031	37	4	rectal	rectal	ADJ
aiua-5031	37	5	examination	examination	NOUN
aiua-5031	37	6	findings	finding	NOUN
aiua-5031	37	7	(	(	PUNCT
aiua-5031	37	8	dre	dre	PROPN
aiua-5031	37	9	)	)	PUNCT
aiua-5031	37	10	were	be	AUX
aiua-5031	37	11	reviewed	review	VERB
aiua-5031	37	12	,	,	PUNCT
aiua-5031	37	13	in	in	ADP
aiua-5031	37	14	71	71	NUM
aiua-5031	37	15	%	%	NOUN
aiua-5031	37	16	of	of	ADP
aiua-5031	37	17	the	the	DET
aiua-5031	37	18	patients	patient	NOUN
aiua-5031	37	19	with	with	ADP
aiua-5031	37	20	bph	bph	NOUN
aiua-5031	37	21	dre	dre	PROPN
aiua-5031	37	22	findings	finding	NOUN
aiua-5031	37	23	were	be	AUX
aiua-5031	37	24	normal	normal	ADJ
aiua-5031	37	25	and	and	CCONJ
aiua-5031	37	26	in	in	ADP
aiua-5031	37	27	29	29	NUM
aiua-5031	37	28	%	%	NOUN
aiua-5031	37	29	were	be	AUX
aiua-5031	37	30	abnormal	abnormal	ADJ
aiua-5031	37	31	,	,	PUNCT
aiua-5031	37	32	whereas	whereas	SCONJ
aiua-5031	37	33	in	in	ADP
aiua-5031	37	34	41.9	41.9	NUM
aiua-5031	37	35	%	%	NOUN
aiua-5031	37	36	of	of	ADP
aiua-5031	37	37	the	the	DET
aiua-5031	37	38	patients	patient	NOUN
aiua-5031	37	39	with	with	ADP
aiua-5031	37	40	adenocarcinoma	adenocarcinoma	ADJ
aiua-5031	37	41	digital	digital	ADJ
aiua-5031	37	42	rectal	rectal	ADJ
aiua-5031	37	43	examination	examination	NOUN
aiua-5031	37	44	findings	finding	NOUN
aiua-5031	37	45	were	be	AUX
aiua-5031	37	46	normal	normal	ADJ
aiua-5031	37	47	and	and	CCONJ
aiua-5031	37	48	in	in	ADP
aiua-5031	37	49	58.1	58.1	NUM
aiua-5031	37	50	%	%	NOUN
aiua-5031	37	51	abnormal	abnormal	ADJ
aiua-5031	37	52	(	(	PUNCT
aiua-5031	37	53	p	p	X
aiua-5031	37	54	<	<	X
aiua-5031	37	55	0.005	0.005	NUM
aiua-5031	37	56	)	)	PUNCT
aiua-5031	37	57	.	.	PUNCT
aiua-5031	38	1	adenocarcinoma	adenocarcinoma	NOUN
aiua-5031	38	2	detection	detection	NOUN
aiua-5031	38	3	rate	rate	NOUN
aiua-5031	38	4	was	be	AUX
aiua-5031	38	5	8.7	8.7	NUM
aiua-5031	38	6	%	%	NOUN
aiua-5031	38	7	in	in	ADP
aiua-5031	38	8	the	the	DET
aiua-5031	38	9	patients	patient	NOUN
aiua-5031	38	10	with	with	ADP
aiua-5031	38	11	normal	normal	ADJ
aiua-5031	38	12	psa	psa	NOUN
aiua-5031	38	13	levels	level	NOUN
aiua-5031	38	14	but	but	CCONJ
aiua-5031	38	15	abnormal	abnormal	ADJ
aiua-5031	38	16	dre	dre	PROPN
aiua-5031	38	17	findings	finding	NOUN
aiua-5031	38	18	,	,	PUNCT
aiua-5031	38	19	41.2	41.2	NUM
aiua-5031	38	20	%	%	NOUN
aiua-5031	38	21	in	in	ADP
aiua-5031	38	22	the	the	DET
aiua-5031	38	23	patients	patient	NOUN
aiua-5031	38	24	with	with	ADP
aiua-5031	38	25	normal	normal	ADJ
aiua-5031	38	26	dre	dre	NOUN
aiua-5031	38	27	findings	finding	NOUN
aiua-5031	38	28	but	but	CCONJ
aiua-5031	38	29	higher	high	ADJ
aiua-5031	38	30	psa	psa	NOUN
aiua-5031	38	31	levels	level	NOUN
aiua-5031	38	32	and	and	CCONJ
aiua-5031	38	33	49.3	49.3	NUM
aiua-5031	38	34	%	%	NOUN
aiua-5031	38	35	in	in	ADP
aiua-5031	38	36	the	the	DET
aiua-5031	38	37	patients	patient	NOUN
aiua-5031	38	38	with	with	ADP
aiua-5031	38	39	both	both	CCONJ
aiua-5031	38	40	higher	high	ADJ
aiua-5031	38	41	psa	psa	NOUN
aiua-5031	38	42	levels	level	NOUN
aiua-5031	38	43	and	and	CCONJ
aiua-5031	38	44	abnormal	abnormal	ADJ
aiua-5031	38	45	dre	dre	PROPN
aiua-5031	38	46	findings	finding	NOUN
aiua-5031	38	47	.	.	PUNCT
aiua-5031	39	1	furthermore	furthermore	ADV
aiua-5031	39	2	,	,	PUNCT
aiua-5031	39	3	cancer	cancer	NOUN
aiua-5031	39	4	was	be	AUX
aiua-5031	39	5	diagnosed	diagnose	VERB
aiua-5031	39	6	in	in	ADP
aiua-5031	39	7	7.5	7.5	NUM
aiua-5031	39	8	%	%	NOUN
aiua-5031	39	9	of	of	ADP
aiua-5031	39	10	the	the	DET
aiua-5031	39	11	patients	patient	NOUN
aiua-5031	39	12	under	under	ADP
aiua-5031	39	13	the	the	DET
aiua-5031	39	14	age	age	NOUN
aiua-5031	39	15	of	of	ADP
aiua-5031	39	16	50	50	NUM
aiua-5031	39	17	,	,	PUNCT
aiua-5031	39	18	14.4	14.4	NUM
aiua-5031	39	19	%	%	NOUN
aiua-5031	39	20	of	of	ADP
aiua-5031	39	21	the	the	DET
aiua-5031	39	22	patients	patient	NOUN
aiua-5031	39	23	between	between	ADP
aiua-5031	39	24	the	the	DET
aiua-5031	39	25	age	age	NOUN
aiua-5031	39	26	of	of	ADP
aiua-5031	39	27	50	50	NUM
aiua-5031	39	28	and	and	CCONJ
aiua-5031	39	29	60	60	NUM
aiua-5031	39	30	,	,	PUNCT
aiua-5031	39	31	27	27	NUM
aiua-5031	39	32	%	%	NOUN
aiua-5031	39	33	of	of	ADP
aiua-5031	39	34	the	the	DET
aiua-5031	39	35	patients	patient	NOUN
aiua-5031	39	36	over	over	ADP
aiua-5031	39	37	the	the	DET
aiua-5031	39	38	age	age	NOUN
aiua-5031	39	39	of	of	ADP
aiua-5031	39	40	70	70	NUM
aiua-5031	39	41	.	.	PUNCT
aiua-5031	40	1	gleason	gleason	PROPN
aiua-5031	40	2	score	score	PROPN
aiua-5031	40	3	was	be	AUX
aiua-5031	40	4	higher	high	ADJ
aiua-5031	40	5	than	than	ADP
aiua-5031	40	6	7	7	NUM
aiua-5031	40	7	in	in	ADP
aiua-5031	40	8	2.5	2.5	NUM
aiua-5031	40	9	%	%	NOUN
aiua-5031	40	10	of	of	ADP
aiua-5031	40	11	the	the	DET
aiua-5031	40	12	patients	patient	NOUN
aiua-5031	40	13	under	under	ADP
aiua-5031	40	14	the	the	DET
aiua-5031	40	15	age	age	NOUN
aiua-5031	40	16	of	of	ADP
aiua-5031	40	17	50	50	NUM
aiua-5031	40	18	,	,	PUNCT
aiua-5031	40	19	in	in	ADP
aiua-5031	40	20	3.7	3.7	NUM
aiua-5031	40	21	%	%	NOUN
aiua-5031	40	22	of	of	ADP
aiua-5031	40	23	the	the	DET
aiua-5031	40	24	patients	patient	NOUN
aiua-5031	40	25	with	with	ADP
aiua-5031	40	26	age	age	NOUN
aiua-5031	40	27	between	between	ADP
aiua-5031	40	28	50	50	NUM
aiua-5031	40	29	and	and	CCONJ
aiua-5031	40	30	70	70	NUM
aiua-5031	40	31	,	,	PUNCT
aiua-5031	40	32	in	in	ADP
aiua-5031	40	33	10.3	10.3	NUM
aiua-5031	40	34	%	%	NOUN
aiua-5031	40	35	of	of	ADP
aiua-5031	40	36	the	the	DET
aiua-5031	40	37	patients	patient	NOUN
aiua-5031	40	38	over	over	ADP
aiua-5031	40	39	the	the	DET
aiua-5031	40	40	age	age	NOUN
aiua-5031	40	41	of	of	ADP
aiua-5031	40	42	70	70	NUM
aiua-5031	40	43	(	(	PUNCT
aiua-5031	40	44	p	p	X
aiua-5031	40	45	<	<	X
aiua-5031	40	46	0.05	0.05	NUM
aiua-5031	40	47	)	)	PUNCT
aiua-5031	40	48	(	(	PUNCT
aiua-5031	40	49	table	table	NOUN
aiua-5031	40	50	3	3	NUM
aiua-5031	40	51	)	)	PUNCT
aiua-5031	40	52	.	.	PUNCT
aiua-5031	41	1	discussion	discussion	NOUN
aiua-5031	41	2	transrectal	transrectal	ADJ
aiua-5031	41	3	ultrasonography	ultrasonography	NOUN
aiua-5031	41	4	guided	guide	VERB
aiua-5031	41	5	prostate	prostate	NOUN
aiua-5031	41	6	biopsy	biopsy	NOUN
aiua-5031	41	7	is	be	AUX
aiua-5031	41	8	the	the	DET
aiua-5031	41	9	main	main	ADJ
aiua-5031	41	10	method	method	NOUN
aiua-5031	41	11	used	use	VERB
aiua-5031	41	12	for	for	ADP
aiua-5031	41	13	diagnosing	diagnose	VERB
aiua-5031	41	14	prostate	prostate	NOUN
aiua-5031	41	15	cancer.9	cancer.9	VERB
aiua-5031	41	16	the	the	DET
aiua-5031	41	17	pathological	pathological	ADJ
aiua-5031	41	18	results	result	NOUN
aiua-5031	41	19	of	of	ADP
aiua-5031	41	20	82.2	82.2	NUM
aiua-5031	41	21	%	%	NOUN
aiua-5031	41	22	of	of	ADP
aiua-5031	41	23	prostate	prostate	NOUN
aiua-5031	41	24	biopsies	biopsy	NOUN
aiua-5031	41	25	were	be	AUX
aiua-5031	41	26	reported	report	VERB
aiua-5031	41	27	as	as	ADP
aiua-5031	41	28	benign	benign	ADJ
aiua-5031	41	29	and	and	CCONJ
aiua-5031	41	30	in	in	ADP
aiua-5031	41	31	66.8	66.8	NUM
aiua-5031	41	32	%	%	NOUN
aiua-5031	41	33	of	of	ADP
aiua-5031	41	34	the	the	DET
aiua-5031	41	35	cases	case	NOUN
aiua-5031	41	36	with	with	ADP
aiua-5031	41	37	benign	benign	ADJ
aiua-5031	41	38	pathological	pathological	ADJ
aiua-5031	41	39	results	result	NOUN
aiua-5031	41	40	,	,	PUNCT
aiua-5031	41	41	psa	psa	VERB
aiua-5031	41	42	levels	level	NOUN
aiua-5031	41	43	before	before	ADP
aiua-5031	41	44	biopsy	biopsy	NOUN
aiua-5031	41	45	procedure	procedure	NOUN
aiua-5031	41	46	were	be	AUX
aiua-5031	41	47	between	between	ADP
aiua-5031	41	48	4	4	NUM
aiua-5031	41	49	and	and	CCONJ
aiua-5031	41	50	10	10	NUM
aiua-5031	41	51	ng	ng	PROPN
aiua-5031	41	52	/	/	SYM
aiua-5031	41	53	dl	dl	PROPN
aiua-5031	41	54	.	.	PROPN
aiua-5031	42	1	on	on	ADP
aiua-5031	42	2	the	the	DET
aiua-5031	42	3	other	other	ADJ
aiua-5031	42	4	hand	hand	NOUN
aiua-5031	42	5	,	,	PUNCT
aiua-5031	42	6	according	accord	VERB
aiua-5031	42	7	to	to	ADP
aiua-5031	42	8	the	the	DET
aiua-5031	42	9	literature	literature	NOUN
aiua-5031	42	10	reviewing	review	VERB
aiua-5031	42	11	the	the	DET
aiua-5031	42	12	two	two	NUM
aiua-5031	42	13	indications	indication	NOUN
aiua-5031	42	14	to	to	ADP
aiua-5031	42	15	prostate	prostate	NOUN
aiua-5031	42	16	biopsy	biopsy	NOUN
aiua-5031	42	17	,	,	PUNCT
aiua-5031	42	18	digital	digital	ADJ
aiua-5031	42	19	rectal	rectal	ADJ
aiua-5031	42	20	examination	examination	NOUN
aiua-5031	42	21	is	be	AUX
aiua-5031	42	22	considered	consider	VERB
aiua-5031	42	23	a	a	DET
aiua-5031	42	24	subjective	subjective	ADJ
aiua-5031	42	25	parameter	parameter	NOUN
aiua-5031	42	26	(	(	PUNCT
aiua-5031	42	27	10	10	NUM
aiua-5031	42	28	)	)	PUNCT
aiua-5031	42	29	.	.	PUNCT
aiua-5031	43	1	there	there	PRON
aiua-5031	43	2	are	be	VERB
aiua-5031	43	3	several	several	ADJ
aiua-5031	43	4	studies	study	NOUN
aiua-5031	43	5	about	about	ADP
aiua-5031	43	6	pathologic	pathologic	ADJ
aiua-5031	43	7	results	result	NOUN
aiua-5031	43	8	of	of	ADP
aiua-5031	43	9	prostate	prostate	NOUN
aiua-5031	43	10	biopsies	biopsy	NOUN
aiua-5031	43	11	performed	perform	VERB
aiua-5031	43	12	because	because	SCONJ
aiua-5031	43	13	of	of	ADP
aiua-5031	43	14	high	high	ADJ
aiua-5031	43	15	psa	psa	NOUN
aiua-5031	43	16	level	level	NOUN
aiua-5031	43	17	and	and	CCONJ
aiua-5031	43	18	abnormal	abnormal	ADJ
aiua-5031	43	19	dre	dre	PROPN
aiua-5031	43	20	findings	finding	NOUN
aiua-5031	43	21	.	.	PUNCT
aiua-5031	44	1	according	accord	VERB
aiua-5031	44	2	to	to	ADP
aiua-5031	44	3	the	the	DET
aiua-5031	44	4	results	result	NOUN
aiua-5031	44	5	of	of	ADP
aiua-5031	44	6	ojewola	ojewola	PROPN
aiua-5031	44	7	et	et	PROPN
aiua-5031	44	8	al	al	PROPN
aiua-5031	44	9	.	.	PUNCT
aiua-5031	45	1	the	the	DET
aiua-5031	45	2	total	total	ADJ
aiua-5031	45	3	average	average	ADJ
aiua-5031	45	4	cancer	cancer	NOUN
aiua-5031	45	5	detection	detection	NOUN
aiua-5031	45	6	rate	rate	NOUN
aiua-5031	45	7	was	be	AUX
aiua-5031	45	8	44	44	NUM
aiua-5031	45	9	%	%	NOUN
aiua-5031	45	10	and	and	CCONJ
aiua-5031	45	11	more	more	ADV
aiua-5031	45	12	specifically	specifically	ADV
aiua-5031	45	13	in	in	ADP
aiua-5031	45	14	presence	presence	NOUN
aiua-5031	45	15	of	of	ADP
aiua-5031	45	16	high	high	ADJ
aiua-5031	45	17	psa	psa	NOUN
aiua-5031	45	18	level	level	NOUN
aiua-5031	45	19	with	with	ADP
aiua-5031	45	20	normal	normal	ADJ
aiua-5031	45	21	dre	dre	NOUN
aiua-5031	45	22	finding	find	VERB
aiua-5031	45	23	the	the	DET
aiua-5031	45	24	rate	rate	NOUN
aiua-5031	45	25	was	be	AUX
aiua-5031	45	26	30	30	NUM
aiua-5031	45	27	%	%	NOUN
aiua-5031	45	28	,	,	PUNCT
aiua-5031	45	29	in	in	ADP
aiua-5031	45	30	presence	presence	NOUN
aiua-5031	45	31	of	of	ADP
aiua-5031	45	32	normal	normal	ADJ
aiua-5031	45	33	psa	psa	NOUN
aiua-5031	45	34	level	level	NOUN
aiua-5031	45	35	and	and	CCONJ
aiua-5031	45	36	abnormal	abnormal	ADJ
aiua-5031	45	37	dre	dre	NOUN
aiua-5031	45	38	finding	find	VERB
aiua-5031	45	39	the	the	DET
aiua-5031	45	40	rate	rate	NOUN
aiua-5031	45	41	was	be	AUX
aiua-5031	45	42	17	17	NUM
aiua-5031	45	43	%	%	NOUN
aiua-5031	45	44	and	and	CCONJ
aiua-5031	45	45	in	in	ADP
aiua-5031	45	46	presence	presence	NOUN
aiua-5031	45	47	of	of	ADP
aiua-5031	45	48	both	both	CCONJ
aiua-5031	45	49	high	high	ADJ
aiua-5031	45	50	psa	psa	NOUN
aiua-5031	45	51	level	level	NOUN
aiua-5031	45	52	and	and	CCONJ
aiua-5031	45	53	abnormal	abnormal	ADJ
aiua-5031	45	54	dre	dre	NOUN
aiua-5031	45	55	finding	find	VERB
aiua-5031	45	56	the	the	DET
aiua-5031	45	57	rate	rate	NOUN
aiua-5031	45	58	was	be	AUX
aiua-5031	45	59	62	62	NUM
aiua-5031	45	60	%	%	NOUN
aiua-5031	45	61	(	(	PUNCT
aiua-5031	45	62	11	11	NUM
aiua-5031	45	63	)	)	PUNCT
aiua-5031	45	64	.	.	PUNCT
aiua-5031	46	1	in	in	ADP
aiua-5031	46	2	the	the	DET
aiua-5031	46	3	study	study	NOUN
aiua-5031	46	4	of	of	ADP
aiua-5031	46	5	shim	shim	NOUN
aiua-5031	46	6	et	et	PROPN
aiua-5031	46	7	al	al	PROPN
aiua-5031	46	8	.	.	PUNCT
aiua-5031	47	1	(	(	PUNCT
aiua-5031	47	2	12	12	NUM
aiua-5031	47	3	)	)	PUNCT
aiua-5031	47	4	the	the	DET
aiua-5031	47	5	patients	patient	NOUN
aiua-5031	47	6	were	be	AUX
aiua-5031	47	7	divided	divide	VERB
aiua-5031	47	8	in	in	ADP
aiua-5031	47	9	two	two	NUM
aiua-5031	47	10	groups	group	NOUN
aiua-5031	47	11	:	:	PUNCT
aiua-5031	47	12	721	721	NUM
aiua-5031	47	13	patients	patient	NOUN
aiua-5031	47	14	with	with	ADP
aiua-5031	47	15	normal	normal	ADJ
aiua-5031	47	16	dre	dre	NOUN
aiua-5031	47	17	findings	finding	NOUN
aiua-5031	47	18	and	and	CCONJ
aiua-5031	47	19	192	192	NUM
aiua-5031	47	20	patients	patient	NOUN
aiua-5031	47	21	with	with	ADP
aiua-5031	47	22	abnormal	abnormal	ADJ
aiua-5031	47	23	dre	dre	PROPN
aiua-5031	47	24	findings	finding	NOUN
aiua-5031	47	25	.	.	PUNCT
aiua-5031	48	1	prostate	prostate	NOUN
aiua-5031	48	2	cancer	cancer	NOUN
aiua-5031	48	3	detection	detection	NOUN
aiua-5031	48	4	rate	rate	NOUN
aiua-5031	48	5	was	be	AUX
aiua-5031	48	6	higher	high	ADJ
aiua-5031	48	7	in	in	ADP
aiua-5031	48	8	the	the	DET
aiua-5031	48	9	group	group	NOUN
aiua-5031	48	10	with	with	ADP
aiua-5031	48	11	abnormal	abnormal	ADJ
aiua-5031	48	12	dre	dre	NOUN
aiua-5031	48	13	findings	finding	NOUN
aiua-5031	48	14	but	but	CCONJ
aiua-5031	48	15	the	the	DET
aiua-5031	48	16	result	result	NOUN
aiua-5031	48	17	was	be	AUX
aiua-5031	48	18	not	not	PART
aiua-5031	48	19	significant	significant	ADJ
aiua-5031	48	20	in	in	ADP
aiua-5031	48	21	the	the	DET
aiua-5031	48	22	patients	patient	NOUN
aiua-5031	48	23	that	that	PRON
aiua-5031	48	24	had	have	VERB
aiua-5031	48	25	psa	psa	NOUN
aiua-5031	48	26	levels	level	NOUN
aiua-5031	48	27	between	between	ADP
aiua-5031	48	28	2.5	2.5	NUM
aiua-5031	48	29	and	and	CCONJ
aiua-5031	48	30	3.9	3.9	NUM
aiua-5031	48	31	ng	ng	PROPN
aiua-5031	48	32	/	/	SYM
aiua-5031	48	33	dl	dl	PROPN
aiua-5031	48	34	and	and	CCONJ
aiua-5031	48	35	also	also	ADV
aiua-5031	48	36	in	in	ADP
aiua-5031	48	37	the	the	DET
aiua-5031	48	38	patients	patient	NOUN
aiua-5031	48	39	with	with	ADP
aiua-5031	48	40	age	age	NOUN
aiua-5031	48	41	between	between	ADP
aiua-5031	48	42	45	45	NUM
aiua-5031	48	43	and	and	CCONJ
aiua-5031	48	44	59	59	NUM
aiua-5031	48	45	(	(	PUNCT
aiua-5031	48	46	12	12	NUM
aiua-5031	48	47	)	)	PUNCT
aiua-5031	48	48	.	.	PUNCT
aiua-5031	49	1	in	in	ADP
aiua-5031	49	2	another	another	DET
aiua-5031	49	3	study	study	NOUN
aiua-5031	49	4	of	of	ADP
aiua-5031	49	5	thompson	thompson	PROPN
aiua-5031	49	6	et	et	PROPN
aiua-5031	49	7	al	al	PROPN
aiua-5031	49	8	,	,	PUNCT
aiua-5031	49	9	including	include	VERB
aiua-5031	49	10	2950	2950	NUM
aiua-5031	49	11	patients	patient	NOUN
aiua-5031	49	12	,	,	PUNCT
aiua-5031	49	13	cancer	cancer	NOUN
aiua-5031	49	14	detection	detection	NOUN
aiua-5031	49	15	rate	rate	NOUN
aiua-5031	49	16	was	be	AUX
aiua-5031	49	17	6.6	6.6	NUM
aiua-5031	49	18	%	%	NOUN
aiua-5031	49	19	for	for	ADP
aiua-5031	49	20	the	the	DET
aiua-5031	49	21	patients	patient	NOUN
aiua-5031	49	22	with	with	ADP
aiua-5031	49	23	psa	psa	NOUN
aiua-5031	49	24	level	level	NOUN
aiua-5031	49	25	<	<	X
aiua-5031	49	26	0.5	0.5	NUM
aiua-5031	49	27	ng	ng	PROPN
aiua-5031	49	28	/	/	SYM
aiua-5031	49	29	dl	dl	PROPN
aiua-5031	49	30	,	,	PUNCT
aiua-5031	49	31	10.1	10.1	NUM
aiua-5031	49	32	%	%	NOUN
aiua-5031	49	33	for	for	ADP
aiua-5031	49	34	the	the	DET
aiua-5031	49	35	patients	patient	NOUN
aiua-5031	49	36	with	with	ADP
aiua-5031	49	37	psa	psa	NOUN
aiua-5031	49	38	level	level	NOUN
aiua-5031	49	39	between	between	ADP
aiua-5031	49	40	0.6	0.6	NUM
aiua-5031	49	41	and	and	CCONJ
aiua-5031	49	42	1	1	NUM
aiua-5031	49	43	ng	ng	PROPN
aiua-5031	49	44	/	/	SYM
aiua-5031	49	45	dl	dl	PROPN
aiua-5031	49	46	,	,	PUNCT
aiua-5031	49	47	17	17	NUM
aiua-5031	49	48	%	%	NOUN
aiua-5031	49	49	for	for	ADP
aiua-5031	49	50	patients	patient	NOUN
aiua-5031	49	51	with	with	ADP
aiua-5031	49	52	psa	psa	NOUN
aiua-5031	49	53	level	level	NOUN
aiua-5031	49	54	between	between	ADP
aiua-5031	49	55	1.1	1.1	NUM
aiua-5031	49	56	and	and	CCONJ
aiua-5031	49	57	2.0	2.0	NUM
aiua-5031	49	58	ng	ng	PROPN
aiua-5031	49	59	/	/	SYM
aiua-5031	49	60	dl	dl	PROPN
aiua-5031	49	61	,	,	PUNCT
aiua-5031	49	62	23.9	23.9	NUM
aiua-5031	49	63	%	%	NOUN
aiua-5031	49	64	for	for	ADP
aiua-5031	49	65	patients	patient	NOUN
aiua-5031	49	66	with	with	ADP
aiua-5031	49	67	psa	psa	NOUN
aiua-5031	49	68	level	level	NOUN
aiua-5031	49	69	between	between	ADP
aiua-5031	49	70	2.1	2.1	NUM
aiua-5031	49	71	and	and	CCONJ
aiua-5031	49	72	3.0	3.0	NUM
aiua-5031	49	73	ng	ng	PROPN
aiua-5031	49	74	/	/	SYM
aiua-5031	49	75	dl	dl	PROPN
aiua-5031	49	76	and	and	CCONJ
aiua-5031	49	77	26.9	26.9	NUM
aiua-5031	49	78	%	%	NOUN
aiua-5031	49	79	for	for	ADP
aiua-5031	49	80	patients	patient	NOUN
aiua-5031	49	81	with	with	ADP
aiua-5031	49	82	psa	psa	NOUN
aiua-5031	49	83	level	level	NOUN
aiua-5031	49	84	between	between	ADP
aiua-5031	49	85	3.1	3.1	NUM
aiua-5031	49	86	and	and	CCONJ
aiua-5031	49	87	4	4	NUM
aiua-5031	49	88	ng	ng	PROPN
aiua-5031	49	89	/	/	SYM
aiua-5031	49	90	dl	dl	PROPN
aiua-5031	49	91	.	.	PUNCT
aiua-5031	50	1	the	the	DET
aiua-5031	50	2	result	result	NOUN
aiua-5031	50	3	of	of	ADP
aiua-5031	50	4	this	this	DET
aiua-5031	50	5	study	study	NOUN
aiua-5031	50	6	is	be	AUX
aiua-5031	50	7	important	important	ADJ
aiua-5031	50	8	as	as	SCONJ
aiua-5031	50	9	it	it	PRON
aiua-5031	50	10	shows	show	VERB
aiua-5031	50	11	that	that	SCONJ
aiua-5031	50	12	prostate	prostate	NOUN
aiua-5031	50	13	cancer	cancer	NOUN
aiua-5031	50	14	would	would	AUX
aiua-5031	50	15	be	be	AUX
aiua-5031	50	16	detected	detect	VERB
aiua-5031	50	17	also	also	ADV
aiua-5031	50	18	at	at	ADP
aiua-5031	50	19	lower	low	ADJ
aiua-5031	50	20	psa	psa	NOUN
aiua-5031	50	21	levels	level	NOUN
aiua-5031	50	22	(	(	PUNCT
aiua-5031	50	23	13	13	NUM
aiua-5031	50	24	)	)	PUNCT
aiua-5031	50	25	.	.	PUNCT
aiua-5031	51	1	another	another	DET
aiua-5031	51	2	study	study	NOUN
aiua-5031	51	3	by	by	ADP
aiua-5031	51	4	catalona	catalona	PROPN
aiua-5031	51	5	et	et	PROPN
aiua-5031	51	6	al	al	PROPN
aiua-5031	51	7	.	.	PUNCT
aiua-5031	52	1	(	(	PUNCT
aiua-5031	52	2	14	14	NUM
aiua-5031	52	3	)	)	PUNCT
aiua-5031	52	4	about	about	ADP
aiua-5031	52	5	biopsies	biopsy	NOUN
aiua-5031	52	6	performed	perform	VERB
aiua-5031	52	7	only	only	ADV
aiua-5031	52	8	for	for	ADP
aiua-5031	52	9	abnormal	abnormal	ADJ
aiua-5031	52	10	digital	digital	ADJ
aiua-5031	52	11	rectal	rectal	ADJ
aiua-5031	52	12	findings	finding	NOUN
aiua-5031	52	13	demonstrated	demonstrate	VERB
aiua-5031	52	14	a	a	DET
aiua-5031	52	15	cancer	cancer	NOUN
aiua-5031	52	16	detection	detection	NOUN
aiua-5031	52	17	rate	rate	NOUN
aiua-5031	52	18	of	of	ADP
aiua-5031	52	19	0	0	NUM
aiua-5031	52	20	%	%	NOUN
aiua-5031	52	21	.	.	PUNCT
aiua-5031	53	1	this	this	DET
aiua-5031	53	2	rate	rate	NOUN
aiua-5031	53	3	was	be	AUX
aiua-5031	53	4	6	6	NUM
aiua-5031	53	5	%	%	NOUN
aiua-5031	53	6	for	for	ADP
aiua-5031	53	7	the	the	DET
aiua-5031	53	8	study	study	NOUN
aiua-5031	53	9	by	by	ADP
aiua-5031	53	10	brawer	brawer	PROPN
aiua-5031	53	11	et	et	PROPN
aiua-5031	53	12	al	al	PROPN
aiua-5031	53	13	.	.	PROPN
aiua-5031	54	1	(	(	PUNCT
aiua-5031	54	2	15	15	NUM
aiua-5031	54	3	)	)	PUNCT
aiua-5031	54	4	and	and	CCONJ
aiua-5031	54	5	17	17	NUM
aiua-5031	54	6	%	%	NOUN
aiua-5031	54	7	for	for	ADP
aiua-5031	54	8	another	another	DET
aiua-5031	54	9	pathologic	pathologic	ADJ
aiua-5031	54	10	number	number	NOUN
aiua-5031	54	11	abnormal	abnormal	ADJ
aiua-5031	54	12	high	high	ADJ
aiua-5031	54	13	psa	psa	NOUN
aiua-5031	54	14	abnormal	abnormal	ADJ
aiua-5031	54	15	result	result	NOUN
aiua-5031	54	16	of	of	ADP
aiua-5031	54	17	patients	patient	NOUN
aiua-5031	54	18	dre	dre	PROPN
aiua-5031	54	19	level	level	PROPN
aiua-5031	54	20	according	accord	VERB
aiua-5031	54	21	dre	dre	PROPN
aiua-5031	54	22	(	(	PUNCT
aiua-5031	54	23	+	+	NOUN
aiua-5031	54	24	)	)	PUNCT
aiua-5031	54	25	findings	finding	NOUN
aiua-5031	54	26	to	to	PART
aiua-5031	54	27	age	age	VERB
aiua-5031	54	28	high	high	ADJ
aiua-5031	54	29	psa	psa	NOUN
aiua-5031	54	30	levels	level	NOUN
aiua-5031	55	1	2	2	NUM
aiua-5031	55	2	+	+	SYM
aiua-5031	55	3	3	3	NUM
aiua-5031	55	4	adenoca	adenoca	NOUN
aiua-5031	55	5	4	4	NUM
aiua-5031	55	6	3	3	NUM
aiua-5031	55	7	3	3	NUM
aiua-5031	55	8	2	2	NUM
aiua-5031	55	9	3	3	NUM
aiua-5031	55	10	+	+	SYM
aiua-5031	55	11	2	2	NUM
aiua-5031	55	12	adenoca	adenoca	NOUN
aiua-5031	55	13	1	1	NUM
aiua-5031	55	14	1	1	NUM
aiua-5031	55	15	1	1	NUM
aiua-5031	55	16	1	1	NUM
aiua-5031	55	17	3	3	NUM
aiua-5031	55	18	+	+	SYM
aiua-5031	55	19	3	3	NUM
aiua-5031	55	20	adenoca	adenoca	NOUN
aiua-5031	55	21	61	61	NUM
aiua-5031	55	22	30	30	NUM
aiua-5031	55	23	54	54	NUM
aiua-5031	55	24	24	24	NUM
aiua-5031	55	25	3	3	NUM
aiua-5031	55	26	+	+	SYM
aiua-5031	55	27	4	4	NUM
aiua-5031	55	28	adenoca	adenoca	NOUN
aiua-5031	55	29	21	21	NUM
aiua-5031	55	30	10	10	NUM
aiua-5031	55	31	19	19	NUM
aiua-5031	55	32	8	8	NUM
aiua-5031	55	33	4	4	NUM
aiua-5031	55	34	+	+	SYM
aiua-5031	55	35	3	3	NUM
aiua-5031	55	36	adenoca	adenoca	NOUN
aiua-5031	55	37	14	14	NUM
aiua-5031	55	38	8	8	NUM
aiua-5031	55	39	14	14	NUM
aiua-5031	55	40	8	8	NUM
aiua-5031	55	41	4	4	NUM
aiua-5031	55	42	+	+	SYM
aiua-5031	55	43	4	4	NUM
aiua-5031	55	44	adenoca	adenoca	NOUN
aiua-5031	55	45	16	16	NUM
aiua-5031	55	46	11	11	NUM
aiua-5031	55	47	15	15	NUM
aiua-5031	55	48	10	10	NUM
aiua-5031	55	49	5	5	NUM
aiua-5031	55	50	+	+	SYM
aiua-5031	55	51	3	3	NUM
aiua-5031	55	52	adenoca	adenoca	NOUN
aiua-5031	55	53	1	1	NUM
aiua-5031	55	54	1	1	NUM
aiua-5031	55	55	1	1	NUM
aiua-5031	55	56	1	1	NUM
aiua-5031	55	57	4	4	NUM
aiua-5031	55	58	+	+	SYM
aiua-5031	55	59	5	5	NUM
aiua-5031	55	60	adenoca	adenoca	NOUN
aiua-5031	55	61	20	20	NUM
aiua-5031	55	62	14	14	NUM
aiua-5031	55	63	17	17	NUM
aiua-5031	55	64	11	11	NUM
aiua-5031	55	65	5	5	NUM
aiua-5031	55	66	+	+	SYM
aiua-5031	55	67	4	4	NUM
aiua-5031	55	68	adenoca	adenoca	NOUN
aiua-5031	55	69	6	6	NUM
aiua-5031	55	70	6	6	NUM
aiua-5031	55	71	6	6	NUM
aiua-5031	55	72	6	6	NUM
aiua-5031	55	73	5	5	NUM
aiua-5031	55	74	+	+	SYM
aiua-5031	55	75	5	5	NUM
aiua-5031	55	76	adenoca	adenoca	NOUN
aiua-5031	55	77	4	4	NUM
aiua-5031	55	78	2	2	NUM
aiua-5031	55	79	4	4	NUM
aiua-5031	55	80	2	2	NUM
aiua-5031	55	81	total	total	NOUN
aiua-5031	55	82	148	148	NUM
aiua-5031	55	83	86	86	NUM
aiua-5031	55	84	(	(	PUNCT
aiua-5031	55	85	%	%	NOUN
aiua-5031	55	86	58.1	58.1	NUM
aiua-5031	55	87	)	)	PUNCT
aiua-5031	55	88	134	134	NUM
aiua-5031	55	89	(	(	PUNCT
aiua-5031	55	90	%	%	NOUN
aiua-5031	55	91	90.5	90.5	NUM
aiua-5031	55	92	)	)	PUNCT
aiua-5031	55	93	73	73	NUM
aiua-5031	55	94	(	(	PUNCT
aiua-5031	55	95	%	%	NOUN
aiua-5031	55	96	49.3	49.3	NUM
aiua-5031	55	97	)	)	PUNCT
aiua-5031	55	98	table	table	NOUN
aiua-5031	55	99	2	2	NUM
aiua-5031	55	100	.	.	PUNCT
aiua-5031	56	1	the	the	DET
aiua-5031	56	2	distibution	distibution	NOUN
aiua-5031	56	3	of	of	ADP
aiua-5031	56	4	the	the	DET
aiua-5031	56	5	patients	patient	NOUN
aiua-5031	56	6	according	accord	VERB
aiua-5031	56	7	to	to	ADP
aiua-5031	56	8	pathologic	pathologic	ADJ
aiua-5031	56	9	results	result	NOUN
aiua-5031	56	10	and	and	CCONJ
aiua-5031	56	11	relationship	relationship	NOUN
aiua-5031	56	12	between	between	ADP
aiua-5031	56	13	pathologic	pathologic	ADJ
aiua-5031	56	14	results	result	NOUN
aiua-5031	56	15	,	,	PUNCT
aiua-5031	56	16	dre	dre	PROPN
aiua-5031	56	17	findings	finding	NOUN
aiua-5031	56	18	and	and	CCONJ
aiua-5031	56	19	psa	psa	NOUN
aiua-5031	56	20	levels	level	NOUN
aiua-5031	56	21	.	.	PUNCT
aiua-5031	57	1	pathologic	pathologic	ADJ
aiua-5031	57	2	result	result	NOUN
aiua-5031	57	3	number	number	NOUN
aiua-5031	57	4	percentage	percentage	NOUN
aiua-5031	57	5	benign	benign	NOUN
aiua-5031	57	6	656	656	NUM
aiua-5031	57	7	%	%	NOUN
aiua-5031	57	8	78.5	78.5	NUM
aiua-5031	57	9	2	2	NUM
aiua-5031	57	10	+	+	SYM
aiua-5031	57	11	3	3	NUM
aiua-5031	57	12	adenoca	adenoca	NOUN
aiua-5031	57	13	4	4	NUM
aiua-5031	57	14	%	%	NOUN
aiua-5031	57	15	0,5	0,5	NUM
aiua-5031	57	16	3	3	NUM
aiua-5031	57	17	+	+	SYM
aiua-5031	57	18	2	2	NUM
aiua-5031	57	19	adenoca	adenoca	NOUN
aiua-5031	57	20	1	1	NUM
aiua-5031	57	21	%	%	NOUN
aiua-5031	57	22	0,1	0,1	NUM
aiua-5031	57	23	3	3	NUM
aiua-5031	57	24	+	+	SYM
aiua-5031	57	25	3	3	NUM
aiua-5031	57	26	adenoca	adenoca	NOUN
aiua-5031	57	27	61	61	NUM
aiua-5031	57	28	%	%	NOUN
aiua-5031	57	29	7,4	7,4	NUM
aiua-5031	57	30	3	3	NUM
aiua-5031	57	31	+	+	SYM
aiua-5031	57	32	4	4	NUM
aiua-5031	57	33	adenoca	adenoca	NOUN
aiua-5031	57	34	21	21	NUM
aiua-5031	57	35	%	%	NOUN
aiua-5031	57	36	2,5	2,5	NUM
aiua-5031	57	37	4	4	NUM
aiua-5031	57	38	+	+	SYM
aiua-5031	57	39	3	3	NUM
aiua-5031	57	40	adenoca	adenoca	NOUN
aiua-5031	57	41	14	14	NUM
aiua-5031	57	42	%	%	NOUN
aiua-5031	57	43	1,7	1,7	NUM
aiua-5031	57	44	4	4	NUM
aiua-5031	57	45	+	+	SYM
aiua-5031	57	46	4	4	NUM
aiua-5031	57	47	adenoca	adenoca	NOUN
aiua-5031	57	48	16	16	NUM
aiua-5031	57	49	%	%	NOUN
aiua-5031	57	50	1,9	1,9	NUM
aiua-5031	57	51	5	5	NUM
aiua-5031	57	52	+	+	SYM
aiua-5031	57	53	3	3	NUM
aiua-5031	57	54	adenoca	adenoca	NOUN
aiua-5031	57	55	1	1	NUM
aiua-5031	57	56	%	%	NOUN
aiua-5031	57	57	0,1	0,1	NUM
aiua-5031	57	58	4	4	NUM
aiua-5031	57	59	+	+	SYM
aiua-5031	57	60	5	5	NUM
aiua-5031	57	61	adenoca	adenoca	NOUN
aiua-5031	57	62	20	20	NUM
aiua-5031	57	63	%	%	NOUN
aiua-5031	57	64	2,5	2,5	NUM
aiua-5031	57	65	5	5	NUM
aiua-5031	57	66	+	+	SYM
aiua-5031	57	67	4	4	NUM
aiua-5031	57	68	adenoca	adenoca	NOUN
aiua-5031	57	69	6	6	NUM
aiua-5031	57	70	%	%	NOUN
aiua-5031	57	71	0,7	0,7	NUM
aiua-5031	57	72	5	5	NUM
aiua-5031	57	73	+	+	SYM
aiua-5031	57	74	5	5	NUM
aiua-5031	57	75	adenoca	adenoca	NOUN
aiua-5031	57	76	4	4	NUM
aiua-5031	57	77	%	%	NOUN
aiua-5031	57	78	0,4	0,4	NUM
aiua-5031	57	79	asap	asap	NOUN
aiua-5031	57	80	/	/	SYM
aiua-5031	57	81	high	high	ADJ
aiua-5031	57	82	pin	pin	NOUN
aiua-5031	57	83	31	31	NUM
aiua-5031	57	84	%	%	NOUN
aiua-5031	57	85	3.7	3.7	NUM
aiua-5031	57	86	total	total	NOUN
aiua-5031	57	87	835	835	NUM
aiua-5031	57	88	%	%	NOUN
aiua-5031	57	89	100	100	NUM
aiua-5031	57	90	table	table	NOUN
aiua-5031	57	91	1	1	NUM
aiua-5031	57	92	.	.	PUNCT
aiua-5031	58	1	the	the	DET
aiua-5031	58	2	distribution	distribution	NOUN
aiua-5031	58	3	of	of	ADP
aiua-5031	58	4	pathologic	pathologic	ADJ
aiua-5031	58	5	results	result	NOUN
aiua-5031	58	6	and	and	CCONJ
aiua-5031	58	7	gleason	gleason	PROPN
aiua-5031	58	8	scores	score	NOUN
aiua-5031	58	9	of	of	ADP
aiua-5031	58	10	the	the	DET
aiua-5031	58	11	prostate	prostate	NOUN
aiua-5031	58	12	biopsies	biopsy	NOUN
aiua-5031	58	13	.	.	PUNCT
aiua-5031	59	1	age	age	NOUN
aiua-5031	59	2	40	40	NUM
aiua-5031	59	3	-	-	SYM
aiua-5031	59	4	50	50	NUM
aiua-5031	59	5	50	50	NUM
aiua-5031	59	6	-	-	SYM
aiua-5031	59	7	60	60	NUM
aiua-5031	59	8	60	60	NUM
aiua-5031	59	9	-	-	SYM
aiua-5031	59	10	70	70	NUM
aiua-5031	59	11	70	70	NUM
aiua-5031	59	12	↑	↑	NOUN
aiua-5031	59	13	psa	psa	VERB
aiua-5031	59	14	0	0	NUM
aiua-5031	59	15	-	-	SYM
aiua-5031	59	16	4	4	NUM
aiua-5031	59	17	ng	ng	PROPN
aiua-5031	59	18	/	/	SYM
aiua-5031	59	19	dl	dl	PROPN
aiua-5031	59	20	5	5	NUM
aiua-5031	59	21	19	19	NUM
aiua-5031	59	22	23	23	NUM
aiua-5031	59	23	10	10	NUM
aiua-5031	59	24	4	4	NUM
aiua-5031	59	25	-	-	SYM
aiua-5031	59	26	10	10	NUM
aiua-5031	59	27	ng	ng	PROPN
aiua-5031	59	28	/	/	SYM
aiua-5031	59	29	dl	dl	PROPN
aiua-5031	59	30	26	26	NUM
aiua-5031	59	31	112	112	NUM
aiua-5031	59	32	161	161	NUM
aiua-5031	59	33	130	130	NUM
aiua-5031	59	34	>	>	SYM
aiua-5031	59	35	10	10	NUM
aiua-5031	59	36	ng	ng	PROPN
aiua-5031	59	37	/	/	SYM
aiua-5031	59	38	dl	dl	PROPN
aiua-5031	59	39	9	9	NUM
aiua-5031	59	40	26	26	NUM
aiua-5031	59	41	113	113	NUM
aiua-5031	59	42	101	101	NUM
aiua-5031	59	43	total	total	NOUN
aiua-5031	59	44	40	40	NUM
aiua-5031	59	45	157	157	NUM
aiua-5031	59	46	397	397	NUM
aiua-5031	59	47	241	241	NUM
aiua-5031	59	48	table	table	NOUN
aiua-5031	59	49	3	3	NUM
aiua-5031	59	50	.	.	PUNCT
aiua-5031	60	1	the	the	DET
aiua-5031	60	2	age	age	NOUN
aiua-5031	60	3	distribution	distribution	NOUN
aiua-5031	60	4	of	of	ADP
aiua-5031	60	5	psa	psa	NOUN
aiua-5031	60	6	levels	level	NOUN
aiua-5031	60	7	.	.	PUNCT
aiua-5031	61	1	sarikaya_stesura	sarikaya_stesura	NOUN
aiua-5031	61	2	seveso	seveso	VERB
aiua-5031	61	3	22/01/15	22/01/15	PROPN
aiua-5031	61	4	10:01	10:01	NUM
aiua-5031	61	5	pagina	pagina	NOUN
aiua-5031	61	6	289	289	NUM
aiua-5031	61	7	archivio	archivio	NOUN
aiua-5031	61	8	italiano	italiano	X
aiua-5031	61	9	di	di	X
aiua-5031	61	10	urologia	urologia	PROPN
aiua-5031	61	11	e	e	PROPN
aiua-5031	61	12	andrologia	andrologia	NOUN
aiua-5031	61	13	2014	2014	NUM
aiua-5031	61	14	;	;	PUNCT
aiua-5031	61	15	86	86	NUM
aiua-5031	61	16	,	,	PUNCT
aiua-5031	61	17	4	4	NUM
aiua-5031	61	18	s.	s.	PROPN
aiua-5031	61	19	sarıkaya	sarıkaya	PROPN
aiua-5031	61	20	,	,	PUNCT
aiua-5031	61	21	m.	m.	NOUN
aiua-5031	61	22	resorlu	resorlu	PROPN
aiua-5031	61	23	,	,	PUNCT
aiua-5031	61	24	u.	u.	PROPN
aiua-5031	61	25	oguz	oguz	PROPN
aiua-5031	61	26	,	,	PUNCT
aiua-5031	61	27	m.	m.	NOUN
aiua-5031	61	28	yordam	yordam	PROPN
aiua-5031	61	29	,	,	PUNCT
aiua-5031	61	30	o.	o.	PROPN
aiua-5031	61	31	faruk	faruk	PROPN
aiua-5031	61	32	bozkurt	bozkurt	PROPN
aiua-5031	61	33	,	,	PUNCT
aiua-5031	61	34	a.	a.	NOUN
aiua-5031	61	35	unsal	unsal	PROPN
aiua-5031	61	36	290	290	NUM
aiua-5031	61	37	study	study	NOUN
aiua-5031	61	38	by	by	ADP
aiua-5031	61	39	mettlin	mettlin	PROPN
aiua-5031	61	40	et	et	PROPN
aiua-5031	61	41	al	al	PROPN
aiua-5031	61	42	.	.	PROPN
aiua-5031	62	1	(	(	PUNCT
aiua-5031	62	2	16	16	NUM
aiua-5031	62	3	)	)	PUNCT
aiua-5031	62	4	the	the	DET
aiua-5031	62	5	cancer	cancer	NOUN
aiua-5031	62	6	detection	detection	NOUN
aiua-5031	62	7	rate	rate	NOUN
aiua-5031	62	8	of	of	ADP
aiua-5031	62	9	the	the	DET
aiua-5031	62	10	biopsies	biopsy	NOUN
aiua-5031	62	11	performed	perform	VERB
aiua-5031	62	12	only	only	ADV
aiua-5031	62	13	for	for	ADP
aiua-5031	62	14	high	high	ADJ
aiua-5031	62	15	psa	psa	NOUN
aiua-5031	62	16	levels	level	NOUN
aiua-5031	62	17	was	be	AUX
aiua-5031	62	18	16	16	NUM
aiua-5031	62	19	%	%	NOUN
aiua-5031	62	20	in	in	ADP
aiua-5031	62	21	the	the	DET
aiua-5031	62	22	study	study	NOUN
aiua-5031	62	23	by	by	ADP
aiua-5031	62	24	catalona	catalona	PROPN
aiua-5031	62	25	et	et	PROPN
aiua-5031	62	26	al	al	PROPN
aiua-5031	62	27	.	.	PUNCT
aiua-5031	63	1	(	(	PUNCT
aiua-5031	63	2	14	14	NUM
aiua-5031	63	3	)	)	PUNCT
aiua-5031	63	4	and	and	CCONJ
aiua-5031	63	5	19	19	NUM
aiua-5031	63	6	%	%	NOUN
aiua-5031	63	7	for	for	ADP
aiua-5031	63	8	the	the	DET
aiua-5031	63	9	study	study	NOUN
aiua-5031	63	10	by	by	ADP
aiua-5031	63	11	brawer	brawer	PROPN
aiua-5031	63	12	et	et	PROPN
aiua-5031	63	13	al	al	PROPN
aiua-5031	63	14	.	.	PROPN
aiua-5031	64	1	(	(	PUNCT
aiua-5031	64	2	15	15	NUM
aiua-5031	64	3	)	)	PUNCT
aiua-5031	64	4	the	the	DET
aiua-5031	64	5	review	review	NOUN
aiua-5031	64	6	of	of	ADP
aiua-5031	64	7	the	the	DET
aiua-5031	64	8	pathologic	pathologic	ADJ
aiua-5031	64	9	results	result	NOUN
aiua-5031	64	10	of	of	ADP
aiua-5031	64	11	the	the	DET
aiua-5031	64	12	biopsies	biopsy	NOUN
aiua-5031	64	13	performed	perform	VERB
aiua-5031	64	14	for	for	ADP
aiua-5031	64	15	the	the	DET
aiua-5031	64	16	presence	presence	NOUN
aiua-5031	64	17	of	of	ADP
aiua-5031	64	18	both	both	CCONJ
aiua-5031	64	19	high	high	ADJ
aiua-5031	64	20	psa	psa	NOUN
aiua-5031	64	21	levels	level	NOUN
aiua-5031	64	22	and	and	CCONJ
aiua-5031	64	23	abnormal	abnormal	ADJ
aiua-5031	64	24	dre	dre	PROPN
aiua-5031	64	25	findings	finding	NOUN
aiua-5031	64	26	showed	show	VERB
aiua-5031	64	27	a	a	DET
aiua-5031	64	28	cancer	cancer	NOUN
aiua-5031	64	29	detection	detection	NOUN
aiua-5031	64	30	rate	rate	NOUN
aiua-5031	64	31	of	of	ADP
aiua-5031	64	32	33	33	NUM
aiua-5031	64	33	%	%	NOUN
aiua-5031	64	34	in	in	ADP
aiua-5031	64	35	the	the	DET
aiua-5031	64	36	study	study	NOUN
aiua-5031	64	37	by	by	ADP
aiua-5031	64	38	catalona	catalona	PROPN
aiua-5031	64	39	et	et	PROPN
aiua-5031	64	40	al	al	PROPN
aiua-5031	64	41	.	.	PUNCT
aiua-5031	65	1	(	(	PUNCT
aiua-5031	65	2	14	14	NUM
aiua-5031	65	3	)	)	PUNCT
aiua-5031	65	4	,	,	PUNCT
aiua-5031	65	5	16	16	NUM
aiua-5031	65	6	%	%	NOUN
aiua-5031	65	7	in	in	ADP
aiua-5031	65	8	the	the	DET
aiua-5031	65	9	study	study	NOUN
aiua-5031	65	10	by	by	ADP
aiua-5031	65	11	brawer	brawer	PROPN
aiua-5031	65	12	et	et	PROPN
aiua-5031	65	13	al	al	PROPN
aiua-5031	65	14	.	.	PROPN
aiua-5031	66	1	(	(	PUNCT
aiua-5031	66	2	15	15	NUM
aiua-5031	66	3	)	)	PUNCT
aiua-5031	66	4	,	,	PUNCT
aiua-5031	66	5	and	and	CCONJ
aiua-5031	66	6	38	38	NUM
aiua-5031	66	7	%	%	NOUN
aiua-5031	66	8	in	in	ADP
aiua-5031	66	9	the	the	DET
aiua-5031	66	10	study	study	NOUN
aiua-5031	66	11	by	by	ADP
aiua-5031	66	12	mettlin	mettlin	PROPN
aiua-5031	66	13	et	et	PROPN
aiua-5031	66	14	al	al	PROPN
aiua-5031	66	15	.	.	PROPN
aiua-5031	67	1	(	(	PUNCT
aiua-5031	67	2	16	16	NUM
aiua-5031	67	3	)	)	PUNCT
aiua-5031	67	4	.	.	PUNCT
aiua-5031	68	1	in	in	ADP
aiua-5031	68	2	our	our	PRON
aiua-5031	68	3	study	study	NOUN
aiua-5031	68	4	,	,	PUNCT
aiua-5031	68	5	prostate	prostate	NOUN
aiua-5031	68	6	cancer	cancer	NOUN
aiua-5031	68	7	detection	detection	NOUN
aiua-5031	68	8	rate	rate	NOUN
aiua-5031	68	9	was	be	AUX
aiua-5031	68	10	8.7	8.7	NUM
aiua-5031	68	11	%	%	NOUN
aiua-5031	68	12	for	for	ADP
aiua-5031	68	13	the	the	DET
aiua-5031	68	14	patients	patient	NOUN
aiua-5031	68	15	with	with	ADP
aiua-5031	68	16	normal	normal	ADJ
aiua-5031	68	17	psa	psa	NOUN
aiua-5031	68	18	level	level	NOUN
aiua-5031	68	19	but	but	CCONJ
aiua-5031	68	20	abnormal	abnormal	ADJ
aiua-5031	68	21	dre	dre	PROPN
aiua-5031	68	22	finding	finding	NOUN
aiua-5031	68	23	,	,	PUNCT
aiua-5031	68	24	41.2	41.2	NUM
aiua-5031	68	25	%	%	NOUN
aiua-5031	68	26	for	for	ADP
aiua-5031	68	27	the	the	DET
aiua-5031	68	28	patients	patient	NOUN
aiua-5031	68	29	with	with	ADP
aiua-5031	68	30	high	high	ADJ
aiua-5031	68	31	psa	psa	NOUN
aiua-5031	68	32	level	level	NOUN
aiua-5031	68	33	and	and	CCONJ
aiua-5031	68	34	normal	normal	ADJ
aiua-5031	68	35	dre	dre	NOUN
aiua-5031	68	36	and	and	CCONJ
aiua-5031	68	37	49.3	49.3	NUM
aiua-5031	68	38	%	%	NOUN
aiua-5031	68	39	for	for	ADP
aiua-5031	68	40	the	the	DET
aiua-5031	68	41	patients	patient	NOUN
aiua-5031	68	42	with	with	ADP
aiua-5031	68	43	both	both	CCONJ
aiua-5031	68	44	high	high	ADJ
aiua-5031	68	45	psa	psa	NOUN
aiua-5031	68	46	level	level	NOUN
aiua-5031	68	47	and	and	CCONJ
aiua-5031	68	48	abnormal	abnormal	ADJ
aiua-5031	68	49	dre	dre	NOUN
aiua-5031	68	50	finding	finding	NOUN
aiua-5031	68	51	.	.	PUNCT
aiua-5031	69	1	when	when	SCONJ
aiua-5031	69	2	we	we	PRON
aiua-5031	69	3	look	look	VERB
aiua-5031	69	4	at	at	ADP
aiua-5031	69	5	the	the	DET
aiua-5031	69	6	results	result	NOUN
aiua-5031	69	7	of	of	ADP
aiua-5031	69	8	our	our	PRON
aiua-5031	69	9	study	study	NOUN
aiua-5031	69	10	;	;	PUNCT
aiua-5031	69	11	the	the	DET
aiua-5031	69	12	rate	rate	NOUN
aiua-5031	69	13	for	for	ADP
aiua-5031	69	14	the	the	DET
aiua-5031	69	15	patients	patient	NOUN
aiua-5031	69	16	with	with	ADP
aiua-5031	69	17	only	only	ADJ
aiua-5031	69	18	abnormal	abnormal	ADJ
aiua-5031	69	19	dre	dre	NOUN
aiua-5031	69	20	finding	find	VERB
aiua-5031	69	21	is	be	AUX
aiua-5031	69	22	consistent	consistent	ADJ
aiua-5031	69	23	with	with	ADP
aiua-5031	69	24	the	the	DET
aiua-5031	69	25	literature	literature	NOUN
aiua-5031	69	26	,	,	PUNCT
aiua-5031	69	27	but	but	CCONJ
aiua-5031	69	28	the	the	DET
aiua-5031	69	29	rates	rate	NOUN
aiua-5031	69	30	for	for	ADP
aiua-5031	69	31	the	the	DET
aiua-5031	69	32	patients	patient	NOUN
aiua-5031	69	33	with	with	ADP
aiua-5031	69	34	only	only	ADJ
aiua-5031	69	35	high	high	ADJ
aiua-5031	69	36	psa	psa	NOUN
aiua-5031	69	37	level	level	NOUN
aiua-5031	69	38	or	or	CCONJ
aiua-5031	69	39	with	with	ADP
aiua-5031	69	40	both	both	DET
aiua-5031	69	41	two	two	NUM
aiua-5031	69	42	indications	indication	NOUN
aiua-5031	69	43	,	,	PUNCT
aiua-5031	69	44	are	be	AUX
aiua-5031	69	45	higher	high	ADJ
aiua-5031	69	46	than	than	ADP
aiua-5031	69	47	the	the	DET
aiua-5031	69	48	rates	rate	NOUN
aiua-5031	69	49	of	of	ADP
aiua-5031	69	50	literature	literature	NOUN
aiua-5031	69	51	.	.	PUNCT
aiua-5031	70	1	the	the	DET
aiua-5031	70	2	rate	rate	NOUN
aiua-5031	70	3	in	in	ADP
aiua-5031	70	4	presence	presence	NOUN
aiua-5031	70	5	of	of	ADP
aiua-5031	70	6	two	two	NUM
aiua-5031	70	7	indications	indication	NOUN
aiua-5031	70	8	was	be	AUX
aiua-5031	70	9	higher	high	ADJ
aiua-5031	70	10	than	than	ADP
aiua-5031	70	11	in	in	ADP
aiua-5031	70	12	presence	presence	NOUN
aiua-5031	70	13	of	of	ADP
aiua-5031	70	14	only	only	ADV
aiua-5031	70	15	one	one	NUM
aiua-5031	70	16	of	of	ADP
aiua-5031	70	17	the	the	DET
aiua-5031	70	18	indications	indication	NOUN
aiua-5031	70	19	.	.	PUNCT
aiua-5031	71	1	this	this	DET
aiua-5031	71	2	results	result	NOUN
aiua-5031	71	3	shows	show	VERB
aiua-5031	71	4	the	the	DET
aiua-5031	71	5	importance	importance	NOUN
aiua-5031	71	6	of	of	ADP
aiua-5031	71	7	dre	dre	PROPN
aiua-5031	71	8	altough	altough	VERB
aiua-5031	71	9	it	it	PRON
aiua-5031	71	10	is	be	AUX
aiua-5031	71	11	a	a	DET
aiua-5031	71	12	subjective	subjective	ADJ
aiua-5031	71	13	parameter	parameter	NOUN
aiua-5031	71	14	.	.	PUNCT
aiua-5031	72	1	pain	pain	NOUN
aiua-5031	72	2	,	,	PUNCT
aiua-5031	72	3	hemorrhage	hemorrhage	NOUN
aiua-5031	72	4	and	and	CCONJ
aiua-5031	72	5	infection	infection	NOUN
aiua-5031	72	6	are	be	AUX
aiua-5031	72	7	some	some	PRON
aiua-5031	72	8	of	of	ADP
aiua-5031	72	9	the	the	DET
aiua-5031	72	10	complications	complication	NOUN
aiua-5031	72	11	of	of	ADP
aiua-5031	72	12	prostate	prostate	NOUN
aiua-5031	72	13	biopsy	biopsy	NOUN
aiua-5031	72	14	as	as	SCONJ
aiua-5031	72	15	it	it	PRON
aiua-5031	72	16	is	be	AUX
aiua-5031	72	17	an	an	DET
aiua-5031	72	18	invasive	invasive	ADJ
aiua-5031	72	19	procedure	procedure	NOUN
aiua-5031	72	20	and	and	CCONJ
aiua-5031	72	21	the	the	DET
aiua-5031	72	22	rate	rate	NOUN
aiua-5031	72	23	of	of	ADP
aiua-5031	72	24	temporary	temporary	ADJ
aiua-5031	72	25	bacteriemia	bacteriemia	NOUN
aiua-5031	72	26	is	be	AUX
aiua-5031	72	27	70	70	NUM
aiua-5031	72	28	%	%	NOUN
aiua-5031	72	29	and	and	CCONJ
aiua-5031	72	30	the	the	DET
aiua-5031	72	31	rate	rate	NOUN
aiua-5031	72	32	of	of	ADP
aiua-5031	72	33	bacteriuria	bacteriuria	PROPN
aiua-5031	72	34	is	be	AUX
aiua-5031	72	35	53	53	NUM
aiua-5031	72	36	%	%	NOUN
aiua-5031	72	37	(	(	PUNCT
aiua-5031	72	38	6	6	NUM
aiua-5031	72	39	,	,	PUNCT
aiua-5031	72	40	17	17	NUM
aiua-5031	72	41	,	,	PUNCT
aiua-5031	72	42	18	18	NUM
aiua-5031	72	43	)	)	PUNCT
aiua-5031	72	44	.	.	PUNCT
aiua-5031	73	1	according	accord	VERB
aiua-5031	73	2	to	to	ADP
aiua-5031	73	3	our	our	PRON
aiua-5031	73	4	previous	previous	ADJ
aiua-5031	73	5	observations	observation	NOUN
aiua-5031	73	6	,	,	PUNCT
aiua-5031	73	7	there	there	PRON
aiua-5031	73	8	was	be	VERB
aiua-5031	73	9	a	a	DET
aiua-5031	73	10	significant	significant	ADJ
aiua-5031	73	11	relationship	relationship	NOUN
aiua-5031	73	12	between	between	ADP
aiua-5031	73	13	presence	presence	NOUN
aiua-5031	73	14	of	of	ADP
aiua-5031	73	15	prostate	prostate	NOUN
aiua-5031	73	16	cancer	cancer	NOUN
aiua-5031	73	17	and	and	CCONJ
aiua-5031	73	18	risk	risk	NOUN
aiua-5031	73	19	of	of	ADP
aiua-5031	73	20	bleeding	bleed	VERB
aiua-5031	73	21	complication	complication	NOUN
aiua-5031	73	22	after	after	ADP
aiua-5031	73	23	prostate	prostate	NOUN
aiua-5031	73	24	biopsies	biopsy	NOUN
aiua-5031	73	25	(	(	PUNCT
aiua-5031	73	26	19	19	NUM
aiua-5031	73	27	)	)	PUNCT
aiua-5031	73	28	.	.	PUNCT
aiua-5031	74	1	furthermore	furthermore	ADV
aiua-5031	74	2	the	the	DET
aiua-5031	74	3	bleeding	bleed	VERB
aiua-5031	74	4	complication	complication	NOUN
aiua-5031	74	5	was	be	AUX
aiua-5031	74	6	observed	observe	VERB
aiua-5031	74	7	at	at	ADP
aiua-5031	74	8	higher	high	ADJ
aiua-5031	74	9	rates	rate	NOUN
aiua-5031	74	10	for	for	ADP
aiua-5031	74	11	the	the	DET
aiua-5031	74	12	patients	patient	NOUN
aiua-5031	74	13	with	with	ADP
aiua-5031	74	14	higher	high	ADJ
aiua-5031	74	15	gleason	gleason	PROPN
aiua-5031	74	16	scores	score	NOUN
aiua-5031	74	17	(	(	PUNCT
aiua-5031	74	18	19	19	NUM
aiua-5031	74	19	)	)	PUNCT
aiua-5031	74	20	.	.	PUNCT
aiua-5031	75	1	serum	serum	NOUN
aiua-5031	75	2	psa	psa	NOUN
aiua-5031	75	3	level	level	NOUN
aiua-5031	75	4	and	and	CCONJ
aiua-5031	75	5	digital	digital	ADJ
aiua-5031	75	6	rectal	rectal	ADJ
aiua-5031	75	7	examination	examination	NOUN
aiua-5031	75	8	are	be	AUX
aiua-5031	75	9	important	important	ADJ
aiua-5031	75	10	parameters	parameter	NOUN
aiua-5031	75	11	for	for	ADP
aiua-5031	75	12	the	the	DET
aiua-5031	75	13	diagnosis	diagnosis	NOUN
aiua-5031	75	14	and	and	CCONJ
aiua-5031	75	15	the	the	DET
aiua-5031	75	16	choice	choice	NOUN
aiua-5031	75	17	of	of	ADP
aiua-5031	75	18	the	the	DET
aiua-5031	75	19	method	method	NOUN
aiua-5031	75	20	of	of	ADP
aiua-5031	75	21	treatment	treatment	NOUN
aiua-5031	75	22	of	of	ADP
aiua-5031	75	23	prostate	prostate	NOUN
aiua-5031	75	24	cancer	cancer	NOUN
aiua-5031	75	25	.	.	PUNCT
aiua-5031	76	1	the	the	DET
aiua-5031	76	2	cancer	cancer	NOUN
aiua-5031	76	3	detection	detection	NOUN
aiua-5031	76	4	rates	rate	NOUN
aiua-5031	76	5	are	be	AUX
aiua-5031	76	6	higher	high	ADJ
aiua-5031	76	7	when	when	SCONJ
aiua-5031	76	8	are	be	AUX
aiua-5031	76	9	present	present	ADJ
aiua-5031	76	10	both	both	CCONJ
aiua-5031	76	11	high	high	ADJ
aiua-5031	76	12	psa	psa	NOUN
aiua-5031	76	13	levels	level	NOUN
aiua-5031	76	14	according	accord	VERB
aiua-5031	76	15	to	to	ADP
aiua-5031	76	16	age	age	NOUN
aiua-5031	76	17	and	and	CCONJ
aiua-5031	76	18	abnormal	abnormal	ADJ
aiua-5031	76	19	digital	digital	ADJ
aiua-5031	76	20	rectal	rectal	ADJ
aiua-5031	76	21	examination	examination	NOUN
aiua-5031	76	22	findings	finding	NOUN
aiua-5031	76	23	.	.	PUNCT
aiua-5031	77	1	other	other	ADJ
aiua-5031	77	2	results	result	NOUN
aiua-5031	77	3	of	of	ADP
aiua-5031	77	4	our	our	PRON
aiua-5031	77	5	study	study	NOUN
aiua-5031	77	6	that	that	PRON
aiua-5031	77	7	are	be	AUX
aiua-5031	77	8	consistent	consistent	ADJ
aiua-5031	77	9	with	with	ADP
aiua-5031	77	10	the	the	DET
aiua-5031	77	11	literature	literature	NOUN
aiua-5031	77	12	,	,	PUNCT
aiua-5031	77	13	are	be	AUX
aiua-5031	77	14	the	the	DET
aiua-5031	77	15	increase	increase	NOUN
aiua-5031	77	16	of	of	ADP
aiua-5031	77	17	psa	psa	NOUN
aiua-5031	77	18	levels	level	NOUN
aiua-5031	77	19	with	with	ADP
aiua-5031	77	20	age	age	NOUN
aiua-5031	77	21	and	and	CCONJ
aiua-5031	77	22	the	the	DET
aiua-5031	77	23	increase	increase	NOUN
aiua-5031	77	24	of	of	ADP
aiua-5031	77	25	gleason	gleason	PROPN
aiua-5031	77	26	score	score	NOUN
aiua-5031	77	27	with	with	ADP
aiua-5031	77	28	age	age	NOUN
aiua-5031	77	29	.	.	PUNCT
aiua-5031	78	1	there	there	PRON
aiua-5031	78	2	are	be	VERB
aiua-5031	78	3	several	several	ADJ
aiua-5031	78	4	limitations	limitation	NOUN
aiua-5031	78	5	about	about	ADP
aiua-5031	78	6	our	our	PRON
aiua-5031	78	7	study	study	NOUN
aiua-5031	78	8	and	and	CCONJ
aiua-5031	78	9	the	the	DET
aiua-5031	78	10	most	most	ADV
aiua-5031	78	11	important	important	ADJ
aiua-5031	78	12	is	be	AUX
aiua-5031	78	13	that	that	SCONJ
aiua-5031	78	14	the	the	DET
aiua-5031	78	15	free	free	ADJ
aiua-5031	78	16	/	/	SYM
aiua-5031	78	17	total	total	ADJ
aiua-5031	78	18	psa	psa	NOUN
aiua-5031	78	19	ratio	ratio	NOUN
aiua-5031	78	20	was	be	AUX
aiua-5031	78	21	not	not	PART
aiua-5031	78	22	evaluated	evaluate	VERB
aiua-5031	78	23	for	for	ADP
aiua-5031	78	24	the	the	DET
aiua-5031	78	25	patiens	patien	NOUN
aiua-5031	78	26	with	with	ADP
aiua-5031	78	27	the	the	DET
aiua-5031	78	28	psa	psa	NOUN
aiua-5031	78	29	level	level	NOUN
aiua-5031	78	30	between	between	ADP
aiua-5031	78	31	4	4	NUM
aiua-5031	78	32	and	and	CCONJ
aiua-5031	78	33	10	10	NUM
aiua-5031	78	34	ng	ng	PROPN
aiua-5031	78	35	/	/	SYM
aiua-5031	78	36	dl	dl	PROPN
aiua-5031	78	37	.	.	PUNCT
aiua-5031	79	1	in	in	ADP
aiua-5031	79	2	fact	fact	NOUN
aiua-5031	79	3	free	free	ADJ
aiua-5031	79	4	psa	psa	NOUN
aiua-5031	79	5	values	value	NOUN
aiua-5031	79	6	for	for	ADP
aiua-5031	79	7	some	some	DET
aiua-5031	79	8	patients	patient	NOUN
aiua-5031	79	9	were	be	AUX
aiua-5031	79	10	not	not	PART
aiua-5031	79	11	found	find	VERB
aiua-5031	79	12	and	and	CCONJ
aiua-5031	79	13	accordingly	accordingly	ADV
aiua-5031	79	14	this	this	DET
aiua-5031	79	15	parameter	parameter	NOUN
aiua-5031	79	16	was	be	AUX
aiua-5031	79	17	excluded	exclude	VERB
aiua-5031	79	18	from	from	ADP
aiua-5031	79	19	the	the	DET
aiua-5031	79	20	analysis	analysis	NOUN
aiua-5031	79	21	.	.	PUNCT
aiua-5031	80	1	another	another	DET
aiua-5031	80	2	important	important	ADJ
aiua-5031	80	3	limitation	limitation	NOUN
aiua-5031	80	4	was	be	AUX
aiua-5031	80	5	that	that	SCONJ
aiua-5031	80	6	the	the	DET
aiua-5031	80	7	analysis	analysis	NOUN
aiua-5031	80	8	was	be	AUX
aiua-5031	80	9	not	not	PART
aiua-5031	80	10	extended	extend	VERB
aiua-5031	80	11	to	to	PART
aiua-5031	80	12	psa	psa	VERB
aiua-5031	80	13	levels	level	NOUN
aiua-5031	80	14	in	in	ADP
aiua-5031	80	15	the	the	DET
aiua-5031	80	16	follow	follow	NOUN
aiua-5031	80	17	-	-	PUNCT
aiua-5031	80	18	up	up	NOUN
aiua-5031	80	19	and	and	CCONJ
aiua-5031	80	20	to	to	PART
aiua-5031	80	21	re	re	VERB
aiua-5031	80	22	-	-	VERB
aiua-5031	80	23	biopsy	biopsy	ADJ
aiua-5031	80	24	requirements	requirement	NOUN
aiua-5031	80	25	for	for	ADP
aiua-5031	80	26	the	the	DET
aiua-5031	80	27	patients	patient	NOUN
aiua-5031	80	28	with	with	ADP
aiua-5031	80	29	normal	normal	ADJ
aiua-5031	80	30	pathologic	pathologic	ADJ
aiua-5031	80	31	results	result	NOUN
aiua-5031	80	32	.	.	PUNCT
aiua-5031	81	1	despite	despite	SCONJ
aiua-5031	81	2	all	all	DET
aiua-5031	81	3	these	these	PRON
aiua-5031	81	4	,	,	PUNCT
aiua-5031	81	5	we	we	PRON
aiua-5031	81	6	think	think	VERB
aiua-5031	81	7	that	that	SCONJ
aiua-5031	81	8	the	the	DET
aiua-5031	81	9	results	result	NOUN
aiua-5031	81	10	of	of	ADP
aiua-5031	81	11	this	this	DET
aiua-5031	81	12	study	study	NOUN
aiua-5031	81	13	are	be	AUX
aiua-5031	81	14	relevant	relevant	ADJ
aiua-5031	81	15	as	as	SCONJ
aiua-5031	81	16	they	they	PRON
aiua-5031	81	17	show	show	VERB
aiua-5031	81	18	the	the	DET
aiua-5031	81	19	relationship	relationship	NOUN
aiua-5031	81	20	between	between	ADP
aiua-5031	81	21	age	age	NOUN
aiua-5031	81	22	,	,	PUNCT
aiua-5031	81	23	psa	psa	NOUN
aiua-5031	81	24	level	level	NOUN
aiua-5031	81	25	and	and	CCONJ
aiua-5031	81	26	pathologic	pathologic	ADJ
aiua-5031	81	27	stage	stage	NOUN
aiua-5031	81	28	and	and	CCONJ
aiua-5031	81	29	also	also	ADV
aiua-5031	81	30	the	the	DET
aiua-5031	81	31	importance	importance	NOUN
aiua-5031	81	32	of	of	ADP
aiua-5031	81	33	digital	digital	ADJ
aiua-5031	81	34	rectal	rectal	ADJ
aiua-5031	81	35	examination	examination	NOUN
aiua-5031	81	36	.	.	PUNCT
aiua-5031	82	1	references	reference	NOUN
aiua-5031	82	2	1	1	NUM
aiua-5031	82	3	.	.	PUNCT
aiua-5031	83	1	alptekin	alptekin	PROPN
aiua-5031	83	2	a	a	PROPN
aiua-5031	83	3	,	,	PUNCT
aiua-5031	83	4	ozgok	ozgok	PROPN
aiua-5031	83	5	iy	iy	PROPN
aiua-5031	83	6	,	,	PUNCT
aiua-5031	83	7	kilciler	kilciler	PROPN
aiua-5031	83	8	m	m	PROPN
aiua-5031	83	9	,	,	PUNCT
aiua-5031	83	10	et	et	PROPN
aiua-5031	83	11	al	al	PROPN
aiua-5031	83	12	.	.	PUNCT
aiua-5031	84	1	our	our	PRON
aiua-5031	84	2	results	result	NOUN
aiua-5031	84	3	of	of	ADP
aiua-5031	84	4	transrectal	transrectal	ADJ
aiua-5031	84	5	ultrasonography	ultrasonography	NOUN
aiua-5031	84	6	guided	guide	VERB
aiua-5031	84	7	prostate	prostate	NOUN
aiua-5031	84	8	biopsies	biopsy	NOUN
aiua-5031	84	9	.	.	PUNCT
aiua-5031	85	1	turkish	turkish	ADJ
aiua-5031	85	2	journal	journal	PROPN
aiua-5031	85	3	of	of	ADP
aiua-5031	85	4	urology	urology	NOUN
aiua-5031	85	5	.	.	PUNCT
aiua-5031	86	1	1998	1998	NUM
aiua-5031	86	2	;	;	PUNCT
aiua-5031	86	3	24:140	24:140	NUM
aiua-5031	86	4	-	-	SYM
aiua-5031	86	5	144	144	NUM
aiua-5031	86	6	.	.	NOUN
aiua-5031	87	1	2	2	NUM
aiua-5031	87	2	.	.	X
aiua-5031	87	3	jemal	jemal	PROPN
aiua-5031	87	4	a	a	PRON
aiua-5031	87	5	,	,	PUNCT
aiua-5031	87	6	siegel	siegel	PROPN
aiua-5031	87	7	r	r	PROPN
aiua-5031	87	8	,	,	PUNCT
aiua-5031	87	9	ward	ward	NOUN
aiua-5031	87	10	e	e	NOUN
aiua-5031	87	11	,	,	PUNCT
aiua-5031	87	12	et	et	PROPN
aiua-5031	87	13	al	al	PROPN
aiua-5031	87	14	.	.	PUNCT
aiua-5031	88	1	cancer	cancer	NOUN
aiua-5031	88	2	statistics	statistic	NOUN
aiua-5031	88	3	.	.	PUNCT
aiua-5031	89	1	cancer	cancer	NOUN
aiua-5031	89	2	j	j	PROPN
aiua-5031	89	3	clin	clin	PROPN
aiua-5031	89	4	.	.	PUNCT
aiua-5031	89	5	2008	2008	NUM
aiua-5031	89	6	;	;	PUNCT
aiua-5031	89	7	58:71	58:71	NUM
aiua-5031	89	8	-	-	SYM
aiua-5031	89	9	96	96	NUM
aiua-5031	89	10	.	.	PUNCT
aiua-5031	90	1	3	3	X
aiua-5031	90	2	.	.	X
aiua-5031	90	3	carignan	carignan	PROPN
aiua-5031	90	4	a	a	PRON
aiua-5031	90	5	,	,	PUNCT
aiua-5031	90	6	roussy	roussy	PROPN
aiua-5031	90	7	jf	jf	PROPN
aiua-5031	90	8	,	,	PUNCT
aiua-5031	90	9	lapointe	lapointe	PROPN
aiua-5031	90	10	v	v	PROPN
aiua-5031	90	11	,	,	PUNCT
aiua-5031	90	12	et	et	PROPN
aiua-5031	90	13	al	al	PROPN
aiua-5031	90	14	.	.	PUNCT
aiua-5031	91	1	increasing	increase	VERB
aiua-5031	91	2	risk	risk	NOUN
aiua-5031	91	3	of	of	ADP
aiua-5031	91	4	infectious	infectious	ADJ
aiua-5031	91	5	complications	complication	NOUN
aiua-5031	91	6	after	after	ADP
aiua-5031	91	7	transrectal	transrectal	ADJ
aiua-5031	91	8	ultrasound	ultrasound	NOUN
aiua-5031	91	9	-	-	PUNCT
aiua-5031	91	10	guided	guide	VERB
aiua-5031	91	11	prostate	prostate	NOUN
aiua-5031	91	12	biopsies	biopsy	NOUN
aiua-5031	91	13	:	:	PUNCT
aiua-5031	91	14	time	time	NOUN
aiua-5031	91	15	to	to	PART
aiua-5031	91	16	reassess	reassess	VERB
aiua-5031	91	17	antimicrobial	antimicrobial	ADJ
aiua-5031	91	18	prophylaxis	prophylaxis	NOUN
aiua-5031	91	19	?	?	PUNCT
aiua-5031	91	20	.	.	PUNCT
aiua-5031	92	1	eur	eur	PROPN
aiua-5031	92	2	urol	urol	PROPN
aiua-5031	92	3	.	.	PUNCT
aiua-5031	92	4	2012	2012	NUM
aiua-5031	92	5	;	;	PUNCT
aiua-5031	92	6	62:453	62:453	NUM
aiua-5031	92	7	-	-	SYM
aiua-5031	92	8	459	459	NUM
aiua-5031	92	9	.	.	PUNCT
aiua-5031	93	1	4	4	X
aiua-5031	93	2	.	.	X
aiua-5031	93	3	tuygun	tuygun	VERB
aiua-5031	93	4	c	c	NOUN
aiua-5031	93	5	,	,	PUNCT
aiua-5031	93	6	demirel	demirel	NOUN
aiua-5031	93	7	f	f	PROPN
aiua-5031	93	8	,	,	PUNCT
aiua-5031	93	9	imamoglu	imamoglu	PROPN
aiua-5031	93	10	a	a	PROPN
aiua-5031	93	11	,	,	PUNCT
aiua-5031	94	1	et	et	PROPN
aiua-5031	94	2	al	al	PROPN
aiua-5031	94	3	.	.	PROPN
aiua-5031	94	4	comparison	comparison	NOUN
aiua-5031	94	5	of	of	ADP
aiua-5031	94	6	two	two	NUM
aiua-5031	94	7	different	different	ADJ
aiua-5031	94	8	prediction	prediction	NOUN
aiua-5031	94	9	systems	system	NOUN
aiua-5031	94	10	for	for	ADP
aiua-5031	94	11	calculating	calculate	VERB
aiua-5031	94	12	the	the	DET
aiua-5031	94	13	prostate	prostate	NOUN
aiua-5031	94	14	cancer	cancer	NOUN
aiua-5031	94	15	risk	risk	NOUN
aiua-5031	94	16	before	before	ADP
aiua-5031	94	17	prostate	prostate	NOUN
aiua-5031	94	18	biyopsy	biyopsy	NOUN
aiua-5031	94	19	.	.	PUNCT
aiua-5031	95	1	international	international	ADJ
aiua-5031	95	2	haematology	haematology	NOUN
aiua-5031	95	3	-	-	PUNCT
aiua-5031	95	4	oncology	oncology	NOUN
aiua-5031	95	5	journal	journal	NOUN
aiua-5031	95	6	.	.	PUNCT
aiua-5031	95	7	2009	2009	NUM
aiua-5031	95	8	;	;	PUNCT
aiua-5031	95	9	2:75	2:75	NUM
aiua-5031	95	10	-	-	SYM
aiua-5031	95	11	81	81	NUM
aiua-5031	95	12	.	.	PUNCT
aiua-5031	96	1	5	5	X
aiua-5031	96	2	.	.	X
aiua-5031	96	3	ozden	ozden	PROPN
aiua-5031	96	4	e	e	PROPN
aiua-5031	96	5	,	,	PUNCT
aiua-5031	96	6	inal	inal	PROPN
aiua-5031	96	7	t	t	PROPN
aiua-5031	96	8	,	,	PUNCT
aiua-5031	96	9	kupeli	kupeli	PROPN
aiua-5031	96	10	s	s	PROPN
aiua-5031	96	11	,	,	PUNCT
aiua-5031	96	12	et	et	PROPN
aiua-5031	96	13	al	al	PROPN
aiua-5031	96	14	.	.	PUNCT
aiua-5031	97	1	the	the	DET
aiua-5031	97	2	diagnostic	diagnostic	ADJ
aiua-5031	97	3	value	value	NOUN
aiua-5031	97	4	of	of	ADP
aiua-5031	97	5	transrectal	transrectal	ADJ
aiua-5031	97	6	ultrasonography	ultrasonography	NOUN
aiua-5031	97	7	for	for	ADP
aiua-5031	97	8	detecting	detect	VERB
aiua-5031	97	9	the	the	DET
aiua-5031	97	10	prostate	prostate	NOUN
aiua-5031	97	11	cancer	cancer	NOUN
aiua-5031	97	12	of	of	ADP
aiua-5031	97	13	the	the	DET
aiua-5031	97	14	patients	patient	NOUN
aiua-5031	97	15	that	that	PRON
aiua-5031	97	16	have	have	AUX
aiua-5031	97	17	psa	psa	NOUN
aiua-5031	97	18	level	level	NOUN
aiua-5031	97	19	of	of	ADP
aiua-5031	97	20	<	<	X
aiua-5031	97	21	4	4	NUM
aiua-5031	97	22	ng	ng	PROPN
aiua-5031	97	23	/	/	SYM
aiua-5031	97	24	ml	ml	NOUN
aiua-5031	97	25	.	.	PUNCT
aiua-5031	98	1	turkish	turkish	ADJ
aiua-5031	98	2	journal	journal	PROPN
aiua-5031	98	3	of	of	ADP
aiua-5031	98	4	urology	urology	NOUN
aiua-5031	98	5	.	.	PUNCT
aiua-5031	99	1	2004	2004	NUM
aiua-5031	99	2	;	;	PUNCT
aiua-5031	99	3	30:155	30:155	NUM
aiua-5031	99	4	-	-	SYM
aiua-5031	99	5	159	159	NUM
aiua-5031	99	6	.	.	PUNCT
aiua-5031	100	1	6	6	NUM
aiua-5031	100	2	.	.	X
aiua-5031	100	3	erturhan	erturhan	PROPN
aiua-5031	100	4	s	s	PROPN
aiua-5031	100	5	,	,	PUNCT
aiua-5031	100	6	seckiner	seckiner	PROPN
aiua-5031	100	7	i	i	PROPN
aiua-5031	100	8	,	,	PUNCT
aiua-5031	100	9	yagci	yagci	PROPN
aiua-5031	100	10	f	f	PROPN
aiua-5031	100	11	,	,	PUNCT
aiua-5031	100	12	et	et	PROPN
aiua-5031	100	13	al	al	PROPN
aiua-5031	100	14	.	.	PUNCT
aiua-5031	101	1	antibiotic	antibiotic	ADJ
aiua-5031	101	2	prophlaxis	prophlaxis	NOUN
aiua-5031	101	3	for	for	ADP
aiua-5031	101	4	transrectal	transrectal	ADJ
aiua-5031	101	5	ultrasonography	ultrasonography	NOUN
aiua-5031	101	6	guided	guide	VERB
aiua-5031	101	7	prostate	prostate	NOUN
aiua-5031	101	8	biopsy	biopsy	NOUN
aiua-5031	101	9	:	:	PUNCT
aiua-5031	101	10	the	the	DET
aiua-5031	101	11	comparison	comparison	NOUN
aiua-5031	101	12	of	of	ADP
aiua-5031	101	13	two	two	NUM
aiua-5031	101	14	different	different	ADJ
aiua-5031	101	15	antibiotics	antibiotic	NOUN
aiua-5031	101	16	.	.	PUNCT
aiua-5031	102	1	turkish	turkish	ADJ
aiua-5031	102	2	journal	journal	NOUN
aiua-5031	102	3	of	of	ADP
aiua-5031	102	4	urology	urology	NOUN
aiua-5031	102	5	.	.	PUNCT
aiua-5031	103	1	2007	2007	NUM
aiua-5031	103	2	;	;	PUNCT
aiua-5031	103	3	33:487	33:487	NUM
aiua-5031	103	4	-	-	SYM
aiua-5031	103	5	490	490	NUM
aiua-5031	103	6	.	.	NOUN
aiua-5031	103	7	7	7	NUM
aiua-5031	103	8	.	.	X
aiua-5031	103	9	bostwick	bostwick	PROPN
aiua-5031	103	10	dg	dg	PROPN
aiua-5031	103	11	.	.	PUNCT
aiua-5031	104	1	grading	grade	VERB
aiua-5031	104	2	prostate	prostate	NOUN
aiua-5031	104	3	cancer	cancer	NOUN
aiua-5031	104	4	.	.	PUNCT
aiua-5031	105	1	am	be	AUX
aiua-5031	105	2	j	j	PROPN
aiua-5031	105	3	clin	clin	PROPN
aiua-5031	105	4	pathol	pathol	PROPN
aiua-5031	105	5	.	.	PUNCT
aiua-5031	106	1	1994	1994	NUM
aiua-5031	106	2	;	;	PUNCT
aiua-5031	107	1	102:38	102:38	NUM
aiua-5031	107	2	-	-	SYM
aiua-5031	107	3	56	56	NUM
aiua-5031	107	4	.	.	NOUN
aiua-5031	107	5	8	8	NUM
aiua-5031	107	6	.	.	PUNCT
aiua-5031	108	1	gleason	gleason	PROPN
aiua-5031	108	2	df	df	PROPN
aiua-5031	108	3	.	.	PUNCT
aiua-5031	109	1	classification	classification	NOUN
aiua-5031	109	2	of	of	ADP
aiua-5031	109	3	prostatic	prostatic	ADJ
aiua-5031	109	4	carcinoma	carcinoma	NOUN
aiua-5031	109	5	.	.	PUNCT
aiua-5031	110	1	cancer	cancer	NOUN
aiua-5031	110	2	chemoter	chemoter	PROPN
aiua-5031	110	3	rep	rep	PROPN
aiua-5031	110	4	.	.	PROPN
aiua-5031	110	5	1966	1966	NUM
aiua-5031	110	6	;	;	PUNCT
aiua-5031	110	7	50:125	50:125	NUM
aiua-5031	110	8	-	-	SYM
aiua-5031	110	9	8	8	NUM
aiua-5031	110	10	.	.	NOUN
aiua-5031	110	11	9	9	NUM
aiua-5031	110	12	.	.	X
aiua-5031	110	13	akyol	akyol	PROPN
aiua-5031	110	14	i	i	PROPN
aiua-5031	110	15	,	,	PUNCT
aiua-5031	110	16	ates	ates	PROPN
aiua-5031	110	17	f	f	PROPN
aiua-5031	110	18	,	,	PUNCT
aiua-5031	110	19	adayener	adayener	PROPN
aiua-5031	110	20	c	c	NOUN
aiua-5031	110	21	,	,	PUNCT
aiua-5031	110	22	et	et	PROPN
aiua-5031	110	23	al	al	PROPN
aiua-5031	110	24	.	.	PUNCT
aiua-5031	111	1	the	the	DET
aiua-5031	111	2	effects	effect	NOUN
aiua-5031	111	3	of	of	ADP
aiua-5031	111	4	age	age	NOUN
aiua-5031	111	5	,	,	PUNCT
aiua-5031	111	6	prostate	prostate	NOUN
aiua-5031	111	7	volume	volume	NOUN
aiua-5031	111	8	and	and	CCONJ
aiua-5031	111	9	number	number	NOUN
aiua-5031	111	10	of	of	ADP
aiua-5031	111	11	cores	core	NOUN
aiua-5031	111	12	on	on	ADP
aiua-5031	111	13	pain	pain	NOUN
aiua-5031	111	14	score	score	NOUN
aiua-5031	111	15	for	for	ADP
aiua-5031	111	16	transrectal	transrectal	ADJ
aiua-5031	111	17	ultrasonography	ultrasonography	NOUN
aiua-5031	111	18	guided	guide	VERB
aiua-5031	111	19	protate	protate	ADJ
aiua-5031	111	20	biopsy	biopsy	NOUN
aiua-5031	111	21	.	.	PUNCT
aiua-5031	112	1	turkish	turkish	ADJ
aiua-5031	112	2	journal	journal	NOUN
aiua-5031	112	3	of	of	ADP
aiua-5031	112	4	urology	urology	NOUN
aiua-5031	112	5	.	.	PUNCT
aiua-5031	112	6	2008	2008	NUM
aiua-5031	112	7	;	;	PUNCT
aiua-5031	112	8	34:22	34:22	NUM
aiua-5031	112	9	-	-	SYM
aiua-5031	112	10	26	26	NUM
aiua-5031	112	11	.	.	PUNCT
aiua-5031	112	12	10	10	NUM
aiua-5031	112	13	.	.	PUNCT
aiua-5031	113	1	kurtulus	kurtulus	PROPN
aiua-5031	113	2	f	f	PROPN
aiua-5031	113	3	,	,	PUNCT
aiua-5031	113	4	fazlioglu	fazlioglu	NOUN
aiua-5031	113	5	a	a	DET
aiua-5031	113	6	,	,	PUNCT
aiua-5031	113	7	evirgen	evirgen	PROPN
aiua-5031	113	8	m	m	PROPN
aiua-5031	113	9	,	,	PUNCT
aiua-5031	113	10	et	et	PROPN
aiua-5031	113	11	al	al	PROPN
aiua-5031	113	12	.	.	PUNCT
aiua-5031	114	1	the	the	DET
aiua-5031	114	2	accuracy	accuracy	NOUN
aiua-5031	114	3	of	of	ADP
aiua-5031	114	4	digital	digital	ADJ
aiua-5031	114	5	rectal	rectal	ADJ
aiua-5031	114	6	examination	examination	NOUN
aiua-5031	114	7	,	,	PUNCT
aiua-5031	114	8	prostate	prostate	NOUN
aiua-5031	114	9	spesific	spesific	NOUN
aiua-5031	114	10	antigen	antigen	PROPN
aiua-5031	114	11	,	,	PUNCT
aiua-5031	114	12	transrectal	transrectal	ADJ
aiua-5031	114	13	ultrasonography	ultrasonography	NOUN
aiua-5031	114	14	,	,	PUNCT
aiua-5031	114	15	psa	psa	VERB
aiua-5031	114	16	density	density	NOUN
aiua-5031	114	17	,	,	PUNCT
aiua-5031	114	18	free	free	ADJ
aiua-5031	114	19	/	/	SYM
aiua-5031	114	20	total	total	ADJ
aiua-5031	114	21	psa	psa	NOUN
aiua-5031	114	22	ratio	ratio	NOUN
aiua-5031	114	23	for	for	ADP
aiua-5031	114	24	the	the	DET
aiua-5031	114	25	diagnose	diagnose	NOUN
aiua-5031	114	26	of	of	ADP
aiua-5031	114	27	prostate	prostate	NOUN
aiua-5031	114	28	cancer	cancer	NOUN
aiua-5031	114	29	.	.	PUNCT
aiua-5031	115	1	turkish	turkish	ADJ
aiua-5031	115	2	journal	journal	PROPN
aiua-5031	115	3	of	of	ADP
aiua-5031	115	4	urology	urology	NOUN
aiua-5031	115	5	.	.	PUNCT
aiua-5031	116	1	2004	2004	NUM
aiua-5031	116	2	;	;	PUNCT
aiua-5031	116	3	30:40	30:40	NUM
aiua-5031	116	4	-	-	SYM
aiua-5031	116	5	44	44	NUM
aiua-5031	116	6	.	.	PUNCT
aiua-5031	117	1	11	11	NUM
aiua-5031	117	2	.	.	X
aiua-5031	117	3	ojewola	ojewola	PROPN
aiua-5031	117	4	rw	rw	PROPN
aiua-5031	117	5	,	,	PUNCT
aiua-5031	117	6	tijani	tijani	PROPN
aiua-5031	117	7	kh	kh	PROPN
aiua-5031	117	8	,	,	PUNCT
aiua-5031	117	9	jeje	jeje	PROPN
aiua-5031	117	10	ea	ea	PROPN
aiua-5031	117	11	,	,	PUNCT
aiua-5031	117	12	et	et	PROPN
aiua-5031	117	13	al	al	PROPN
aiua-5031	117	14	.	.	PUNCT
aiua-5031	118	1	an	an	DET
aiua-5031	118	2	evaluation	evaluation	NOUN
aiua-5031	118	3	of	of	ADP
aiua-5031	118	4	usefulness	usefulness	NOUN
aiua-5031	118	5	of	of	ADP
aiua-5031	118	6	prostate	prostate	NOUN
aiua-5031	118	7	spesific	spesific	NOUN
aiua-5031	118	8	antigen	antigen	NOUN
aiua-5031	118	9	and	and	CCONJ
aiua-5031	118	10	digital	digital	ADJ
aiua-5031	118	11	rectal	rectal	ADJ
aiua-5031	118	12	examination	examination	NOUN
aiua-5031	118	13	in	in	ADP
aiua-5031	118	14	the	the	DET
aiua-5031	118	15	diagnosis	diagnosis	NOUN
aiua-5031	118	16	of	of	ADP
aiua-5031	118	17	prostate	prostate	NOUN
aiua-5031	118	18	cancer	cancer	NOUN
aiua-5031	118	19	in	in	ADP
aiua-5031	118	20	an	an	DET
aiua-5031	118	21	unscreened	unscreened	ADJ
aiua-5031	118	22	population	population	NOUN
aiua-5031	118	23	:	:	PUNCT
aiua-5031	118	24	experience	experience	NOUN
aiua-5031	118	25	in	in	ADP
aiua-5031	118	26	an	an	DET
aiua-5031	118	27	nigerian	nigerian	ADJ
aiua-5031	118	28	teaching	teaching	NOUN
aiua-5031	118	29	hospital	hospital	NOUN
aiua-5031	118	30	.	.	PUNCT
aiua-5031	119	1	west	west	PROPN
aiua-5031	119	2	afr	afr	PROPN
aiua-5031	119	3	j	j	PROPN
aiua-5031	119	4	med	med	PROPN
aiua-5031	119	5	.	.	PUNCT
aiua-5031	119	6	2013	2013	NUM
aiua-5031	119	7	;	;	PUNCT
aiua-5031	119	8	32:8	32:8	NUM
aiua-5031	119	9	-	-	SYM
aiua-5031	119	10	13	13	NUM
aiua-5031	119	11	.	.	PUNCT
aiua-5031	120	1	12	12	NUM
aiua-5031	120	2	.	.	PUNCT
aiua-5031	121	1	shim	shim	NOUN
aiua-5031	121	2	hb	hb	PROPN
aiua-5031	121	3	,	,	PUNCT
aiua-5031	121	4	lee	lee	PROPN
aiua-5031	121	5	se	se	PROPN
aiua-5031	121	6	,	,	PUNCT
aiua-5031	121	7	park	park	PROPN
aiua-5031	121	8	hk	hk	PROPN
aiua-5031	121	9	,	,	PUNCT
aiua-5031	121	10	ku	ku	PROPN
aiua-5031	121	11	jh	jh	PROPN
aiua-5031	121	12	.	.	PUNCT
aiua-5031	122	1	digital	digital	ADJ
aiua-5031	122	2	rectal	rectal	ADJ
aiua-5031	122	3	examination	examination	NOUN
aiua-5031	122	4	as	as	ADP
aiua-5031	122	5	a	a	DET
aiua-5031	122	6	prostate	prostate	NOUN
aiua-5031	122	7	cancer	cancer	NOUN
aiua-5031	122	8	-	-	PUNCT
aiua-5031	122	9	screening	screen	VERB
aiua-5031	122	10	method	method	NOUN
aiua-5031	122	11	in	in	ADP
aiua-5031	122	12	a	a	DET
aiua-5031	122	13	country	country	NOUN
aiua-5031	122	14	with	with	ADP
aiua-5031	122	15	a	a	DET
aiua-5031	122	16	low	low	ADJ
aiua-5031	122	17	incidence	incidence	NOUN
aiua-5031	122	18	of	of	ADP
aiua-5031	122	19	prostate	prostate	NOUN
aiua-5031	122	20	cancer	cancer	NOUN
aiua-5031	122	21	.	.	PUNCT
aiua-5031	123	1	prostate	prostate	NOUN
aiua-5031	123	2	cancer	cancer	NOUN
aiua-5031	123	3	and	and	CCONJ
aiua-5031	123	4	prostatic	prostatic	ADJ
aiua-5031	123	5	diseases	disease	NOUN
aiua-5031	123	6	.	.	PUNCT
aiua-5031	124	1	2007	2007	NUM
aiua-5031	124	2	;	;	PUNCT
aiua-5031	124	3	10:250	10:250	NUM
aiua-5031	124	4	-	-	SYM
aiua-5031	124	5	255	255	NUM
aiua-5031	124	6	.	.	PUNCT
aiua-5031	125	1	13	13	NUM
aiua-5031	125	2	.	.	X
aiua-5031	126	1	thompson	thompson	PROPN
aiua-5031	127	1	i	i	PRON
aiua-5031	127	2	m	m	VERB
aiua-5031	127	3	,	,	PUNCT
aiua-5031	127	4	pauler	pauler	ADJ
aiua-5031	127	5	dk	dk	PROPN
aiua-5031	127	6	,	,	PUNCT
aiua-5031	127	7	goodman	goodman	PROPN
aiua-5031	127	8	pj	pj	PROPN
aiua-5031	127	9	,	,	PUNCT
aiua-5031	127	10	et	et	PROPN
aiua-5031	127	11	al	al	PROPN
aiua-5031	127	12	.	.	PUNCT
aiua-5031	128	1	prevalence	prevalence	NOUN
aiua-5031	128	2	of	of	ADP
aiua-5031	128	3	prostate	prostate	NOUN
aiua-5031	128	4	cancer	cancer	NOUN
aiua-5031	128	5	among	among	ADP
aiua-5031	128	6	men	man	NOUN
aiua-5031	128	7	with	with	ADP
aiua-5031	128	8	a	a	DET
aiua-5031	128	9	prostate	prostate	NOUN
aiua-5031	128	10	-	-	PUNCT
aiua-5031	128	11	specific	specific	ADJ
aiua-5031	128	12	antigen	antigen	ADJ
aiua-5031	128	13	level	level	NOUN
aiua-5031	128	14	≤	≤	NUM
aiua-5031	128	15	4.0	4.0	NUM
aiua-5031	128	16	ng	ng	NOUN
aiua-5031	128	17	per	per	ADP
aiua-5031	128	18	milliliter	milliliter	NOUN
aiua-5031	128	19	.	.	PUNCT
aiua-5031	129	1	n	n	PROPN
aiua-5031	129	2	engl	engl	PROPN
aiua-5031	129	3	j	j	PROPN
aiua-5031	129	4	med	med	PROPN
aiua-5031	129	5	.	.	PUNCT
aiua-5031	129	6	2004	2004	NUM
aiua-5031	129	7	;	;	PUNCT
aiua-5031	130	1	350:2239	350:2239	NUM
aiua-5031	130	2	-	-	SYM
aiua-5031	130	3	46	46	NUM
aiua-5031	130	4	.	.	PUNCT
aiua-5031	131	1	14	14	NUM
aiua-5031	131	2	.	.	PUNCT
aiua-5031	132	1	catalona	catalona	PROPN
aiua-5031	132	2	w	w	PROPN
aiua-5031	132	3	,	,	PUNCT
aiua-5031	132	4	smith	smith	PROPN
aiua-5031	132	5	d	d	PROPN
aiua-5031	132	6	,	,	PUNCT
aiua-5031	132	7	ratcliff	ratcliff	PROPN
aiua-5031	132	8	t	t	PROPN
aiua-5031	132	9	,	,	PUNCT
aiua-5031	132	10	et	et	PROPN
aiua-5031	132	11	al	al	PROPN
aiua-5031	132	12	.	.	PROPN
aiua-5031	132	13	measurement	measurement	NOUN
aiua-5031	132	14	of	of	ADP
aiua-5031	132	15	prostate	prostate	NOUN
aiua-5031	132	16	specific	specific	ADJ
aiua-5031	132	17	antigen	antigen	NOUN
aiua-5031	132	18	in	in	ADP
aiua-5031	132	19	serum	serum	NOUN
aiua-5031	132	20	as	as	ADP
aiua-5031	132	21	a	a	DET
aiua-5031	132	22	screening	screening	NOUN
aiua-5031	132	23	test	test	NOUN
aiua-5031	132	24	for	for	ADP
aiua-5031	132	25	prostate	prostate	NOUN
aiua-5031	132	26	cancer	cancer	NOUN
aiua-5031	132	27	.	.	PUNCT
aiua-5031	133	1	n	n	PROPN
aiua-5031	133	2	engl	engl	PROPN
aiua-5031	133	3	j	j	PROPN
aiua-5031	133	4	med	med	PROPN
aiua-5031	133	5	.	.	PROPN
aiua-5031	133	6	1991	1991	NUM
aiua-5031	133	7	;	;	PUNCT
aiua-5031	133	8	324:1156	324:1156	NUM
aiua-5031	133	9	-	-	NOUN
aiua-5031	133	10	1161	1161	NUM
aiua-5031	133	11	.	.	PUNCT
aiua-5031	134	1	15	15	NUM
aiua-5031	134	2	.	.	PUNCT
aiua-5031	134	3	brawer	brawer	PROPN
aiua-5031	134	4	mk	mk	PROPN
aiua-5031	134	5	,	,	PUNCT
aiua-5031	134	6	aramburu	aramburu	PROPN
aiua-5031	134	7	eag	eag	PROPN
aiua-5031	134	8	,	,	PUNCT
aiua-5031	134	9	chen	chen	PROPN
aiua-5031	134	10	gl	gl	PROPN
aiua-5031	134	11	,	,	PUNCT
aiua-5031	134	12	et	et	PROPN
aiua-5031	134	13	al	al	PROPN
aiua-5031	134	14	.	.	PUNCT
aiua-5031	135	1	the	the	DET
aiua-5031	135	2	inability	inability	NOUN
aiua-5031	135	3	of	of	ADP
aiua-5031	135	4	psa	psa	NOUN
aiua-5031	135	5	index	index	NOUN
aiua-5031	135	6	to	to	PART
aiua-5031	135	7	enhance	enhance	VERB
aiua-5031	135	8	the	the	DET
aiua-5031	135	9	predictive	predictive	ADJ
aiua-5031	135	10	value	value	NOUN
aiua-5031	135	11	of	of	ADP
aiua-5031	135	12	psa	psa	NOUN
aiua-5031	135	13	in	in	ADP
aiua-5031	135	14	the	the	DET
aiua-5031	135	15	diagnosis	diagnosis	NOUN
aiua-5031	135	16	of	of	ADP
aiua-5031	135	17	prostatic	prostatic	ADJ
aiua-5031	135	18	carcinoma	carcinoma	NOUN
aiua-5031	135	19	.	.	PUNCT
aiua-5031	136	1	j	j	PROPN
aiua-5031	136	2	urol	urol	PROPN
aiua-5031	136	3	.	.	PUNCT
aiua-5031	136	4	1993	1993	NUM
aiua-5031	136	5	;	;	PUNCT
aiua-5031	136	6	150:369	150:369	PROPN
aiua-5031	136	7	-	-	PUNCT
aiua-5031	136	8	373	373	NUM
aiua-5031	136	9	.	.	PUNCT
aiua-5031	137	1	16	16	NUM
aiua-5031	137	2	.	.	PUNCT
aiua-5031	138	1	mettlin	mettlin	PROPN
aiua-5031	138	2	c	c	PROPN
aiua-5031	138	3	,	,	PUNCT
aiua-5031	138	4	lee	lee	PROPN
aiua-5031	138	5	f	f	AUX
aiua-5031	138	6	,	,	PUNCT
aiua-5031	138	7	drago	drago	PROPN
aiua-5031	138	8	j	j	PROPN
aiua-5031	138	9	,	,	PUNCT
aiua-5031	138	10	et	et	PROPN
aiua-5031	138	11	al	al	PROPN
aiua-5031	138	12	.	.	PUNCT
aiua-5031	139	1	the	the	DET
aiua-5031	139	2	american	american	PROPN
aiua-5031	139	3	cancer	cancer	PROPN
aiua-5031	139	4	society	society	PROPN
aiua-5031	139	5	national	national	ADJ
aiua-5031	139	6	prostate	prostate	NOUN
aiua-5031	139	7	cancer	cancer	NOUN
aiua-5031	139	8	detection	detection	NOUN
aiua-5031	139	9	project	project	NOUN
aiua-5031	139	10	finding	find	VERB
aiua-5031	139	11	on	on	ADP
aiua-5031	139	12	the	the	DET
aiua-5031	139	13	detection	detection	NOUN
aiua-5031	139	14	of	of	ADP
aiua-5031	139	15	early	early	ADJ
aiua-5031	139	16	prostate	prostate	NOUN
aiua-5031	139	17	cancer	cancer	NOUN
aiua-5031	139	18	in	in	ADP
aiua-5031	139	19	2425	2425	NUM
aiua-5031	139	20	men	man	NOUN
aiua-5031	139	21	.	.	PUNCT
aiua-5031	140	1	cancer	cancer	NOUN
aiua-5031	140	2	.	.	PUNCT
aiua-5031	141	1	1991	1991	NUM
aiua-5031	141	2	;	;	PUNCT
aiua-5031	141	3	67:2949	67:2949	NUM
aiua-5031	141	4	-	-	SYM
aiua-5031	141	5	2958	2958	NUM
aiua-5031	141	6	.	.	PUNCT
aiua-5031	142	1	17	17	NUM
aiua-5031	142	2	.	.	PUNCT
aiua-5031	143	1	ruebush	ruebush	PROPN
aiua-5031	143	2	tk	tk	PROPN
aiua-5031	143	3	,	,	PUNCT
aiua-5031	143	4	mcconville	mcconville	PROPN
aiua-5031	143	5	jh	jh	PROPN
aiua-5031	143	6	,	,	PUNCT
aiua-5031	143	7	calia	calia	PROPN
aiua-5031	143	8	fm	fm	PROPN
aiua-5031	143	9	.	.	PUNCT
aiua-5031	144	1	a	a	DET
aiua-5031	144	2	double	double	ADJ
aiua-5031	144	3	-	-	PUNCT
aiua-5031	144	4	blind	blind	ADJ
aiua-5031	144	5	study	study	NOUN
aiua-5031	144	6	of	of	ADP
aiua-5031	144	7	trimetoprim	trimetoprim	NOUN
aiua-5031	144	8	-	-	PUNCT
aiua-5031	144	9	sulfamethoxazole	sulfamethoxazole	NOUN
aiua-5031	144	10	prophylaxis	prophylaxis	NOUN
aiua-5031	144	11	in	in	ADP
aiua-5031	144	12	patients	patient	NOUN
aiua-5031	144	13	having	have	VERB
aiua-5031	144	14	transrectal	transrectal	ADJ
aiua-5031	144	15	needle	needle	NOUN
aiua-5031	144	16	biopsy	biopsy	NOUN
aiua-5031	144	17	of	of	ADP
aiua-5031	144	18	the	the	DET
aiua-5031	144	19	prostate	prostate	NOUN
aiua-5031	144	20	.	.	PUNCT
aiua-5031	145	1	j	j	PROPN
aiua-5031	145	2	urol	urol	PROPN
aiua-5031	145	3	.	.	PUNCT
aiua-5031	146	1	1979	1979	NUM
aiua-5031	146	2	;	;	PUNCT
aiua-5031	146	3	122:492	122:492	NUM
aiua-5031	146	4	-	-	PUNCT
aiua-5031	146	5	494	494	NUM
aiua-5031	146	6	.	.	NOUN
aiua-5031	146	7	18	18	NUM
aiua-5031	146	8	.	.	X
aiua-5031	147	1	melekos	melekos	PROPN
aiua-5031	147	2	md	md	PROPN
aiua-5031	147	3	.	.	PROPN
aiua-5031	148	1	eficacy	eficacy	PROPN
aiua-5031	148	2	of	of	ADP
aiua-5031	148	3	prophylactic	prophylactic	ADJ
aiua-5031	148	4	antimicrobial	antimicrobial	ADJ
aiua-5031	148	5	regimens	regimen	NOUN
aiua-5031	148	6	in	in	ADP
aiua-5031	148	7	preventing	prevent	VERB
aiua-5031	148	8	infectious	infectious	ADJ
aiua-5031	148	9	complications	complication	NOUN
aiua-5031	148	10	after	after	ADP
aiua-5031	148	11	transrectal	transrectal	ADJ
aiua-5031	148	12	biopsy	biopsy	NOUN
aiua-5031	148	13	of	of	ADP
aiua-5031	148	14	the	the	DET
aiua-5031	148	15	prostate	prostate	NOUN
aiua-5031	148	16	.	.	PUNCT
aiua-5031	149	1	int	int	PROPN
aiua-5031	149	2	urol	urol	ADJ
aiua-5031	149	3	nephrol	nephrol	NOUN
aiua-5031	149	4	.	.	PUNCT
aiua-5031	149	5	1990	1990	NUM
aiua-5031	149	6	;	;	PUNCT
aiua-5031	149	7	22:257	22:257	NUM
aiua-5031	149	8	-	-	SYM
aiua-5031	149	9	262	262	NUM
aiua-5031	149	10	.	.	NOUN
aiua-5031	150	1	19	19	NUM
aiua-5031	150	2	.	.	PUNCT
aiua-5031	150	3	oguz	oguz	PROPN
aiua-5031	150	4	u	u	PROPN
aiua-5031	150	5	,	,	PUNCT
aiua-5031	150	6	resorlu	resorlu	ADJ
aiua-5031	150	7	b	b	NOUN
aiua-5031	150	8	,	,	PUNCT
aiua-5031	150	9	bayindir	bayindir	PROPN
aiua-5031	150	10	m	m	PROPN
aiua-5031	150	11	,	,	PUNCT
aiua-5031	150	12	unsal	unsal	PROPN
aiua-5031	150	13	a.	a.	NOUN
aiua-5031	150	14	does	do	VERB
aiua-5031	150	15	existance	existance	NOUN
aiua-5031	150	16	of	of	ADP
aiua-5031	150	17	prostate	prostate	NOUN
aiua-5031	150	18	cancer	cancer	NOUN
aiua-5031	150	19	increase	increase	NOUN
aiua-5031	150	20	the	the	DET
aiua-5031	150	21	risk	risk	NOUN
aiua-5031	150	22	of	of	ADP
aiua-5031	150	23	bleeding	bleed	VERB
aiua-5031	150	24	as	as	ADP
aiua-5031	150	25	a	a	DET
aiua-5031	150	26	complication	complication	NOUN
aiua-5031	150	27	of	of	ADP
aiua-5031	150	28	transrectal	transrectal	ADJ
aiua-5031	150	29	ultrasonography	ultrasonography	NOUN
aiua-5031	150	30	guided	guide	VERB
aiua-5031	150	31	prostate	prostate	NOUN
aiua-5031	150	32	needle	needle	NOUN
aiua-5031	150	33	biopsies	biopsy	NOUN
aiua-5031	150	34	?	?	PUNCT
aiua-5031	151	1	turkish	turkish	ADJ
aiua-5031	151	2	clinics	clinic	NOUN
aiua-5031	151	3	j	j	PROPN
aiua-5031	151	4	urology	urology	NOUN
aiua-5031	151	5	.	.	PUNCT
aiua-5031	151	6	2012	2012	NUM
aiua-5031	151	7	;	;	PUNCT
aiua-5031	151	8	3:41	3:41	NUM
aiua-5031	151	9	-	-	SYM
aiua-5031	151	10	5	5	NUM
aiua-5031	151	11	.	.	PUNCT
aiua-5031	151	12	correspondence	correspondence	NOUN
aiua-5031	151	13	selcuk	selcuk	PROPN
aiua-5031	151	14	sarıkaya	sarıkaya	PROPN
aiua-5031	151	15	,	,	PUNCT
aiua-5031	151	16	md	md	PROPN
aiua-5031	151	17	mustafa	mustafa	PROPN
aiua-5031	151	18	yordam	yordam	PROPN
aiua-5031	151	19	,	,	PUNCT
aiua-5031	151	20	md	md	PROPN
aiua-5031	151	21	omer	omer	PROPN
aiua-5031	151	22	faruk	faruk	PROPN
aiua-5031	151	23	bozkurt	bozkurt	PROPN
aiua-5031	151	24	,	,	PUNCT
aiua-5031	151	25	md	md	PROPN
aiua-5031	151	26	ali	ali	PROPN
aiua-5031	151	27	unsal	unsal	PROPN
aiua-5031	151	28	,	,	PUNCT
aiua-5031	151	29	md	md	PROPN
aiua-5031	151	30	keçioren	keçioren	PROPN
aiua-5031	151	31	training	training	NOUN
aiua-5031	151	32	and	and	CCONJ
aiua-5031	151	33	research	research	NOUN
aiua-5031	151	34	hospital	hospital	NOUN
aiua-5031	151	35	,	,	PUNCT
aiua-5031	151	36	departmant	departmant	ADJ
aiua-5031	151	37	of	of	ADP
aiua-5031	151	38	urology	urology	NOUN
aiua-5031	151	39	,	,	PUNCT
aiua-5031	151	40	ankara	ankara	PROPN
aiua-5031	151	41	,	,	PUNCT
aiua-5031	151	42	turkey	turkey	PROPN
aiua-5031	151	43	mustafa	mustafa	PROPN
aiua-5031	151	44	resorlu	resorlu	PROPN
aiua-5031	151	45	,	,	PUNCT
aiua-5031	151	46	md	md	PROPN
aiua-5031	151	47	mustafaresorlu77@gmail.com	mustafaresorlu77@gmail.com	PROPN
aiua-5031	151	48	canakkale	canakkale	PROPN
aiua-5031	151	49	onsekiz	onsekiz	PROPN
aiua-5031	151	50	mart	mart	PROPN
aiua-5031	151	51	university	university	PROPN
aiua-5031	151	52	,	,	PUNCT
aiua-5031	151	53	faculty	faculty	NOUN
aiua-5031	151	54	of	of	ADP
aiua-5031	151	55	medicine	medicine	NOUN
aiua-5031	151	56	,	,	PUNCT
aiua-5031	151	57	departmant	departmant	ADJ
aiua-5031	151	58	of	of	ADP
aiua-5031	151	59	radiology	radiology	NOUN
aiua-5031	151	60	,	,	PUNCT
aiua-5031	151	61	terzioglu	terzioglu	NOUN
aiua-5031	151	62	yerleskesi	yerleskesi	NOUN
aiua-5031	151	63	,	,	PUNCT
aiua-5031	151	64	barbaros	barbaros	PROPN
aiua-5031	151	65	mh	mh	PROPN
aiua-5031	151	66	,	,	PUNCT
aiua-5031	151	67	17100	17100	NUM
aiua-5031	151	68	,	,	PUNCT
aiua-5031	151	69	canakkale	canakkale	ADJ
aiua-5031	151	70	ural	ural	ADJ
aiua-5031	151	71	oguz	oguz	PROPN
aiua-5031	151	72	,	,	PUNCT
aiua-5031	151	73	md	md	PROPN
aiua-5031	151	74	giresun	giresun	PROPN
aiua-5031	151	75	university	university	PROPN
aiua-5031	151	76	,	,	PUNCT
aiua-5031	151	77	faculty	faculty	NOUN
aiua-5031	151	78	of	of	ADP
aiua-5031	151	79	medicine	medicine	NOUN
aiua-5031	151	80	,	,	PUNCT
aiua-5031	151	81	departmant	departmant	ADJ
aiua-5031	151	82	of	of	ADP
aiua-5031	151	83	urology	urology	NOUN
aiua-5031	151	84	,	,	PUNCT
aiua-5031	151	85	giresun	giresun	PROPN
aiua-5031	151	86	,	,	PUNCT
aiua-5031	151	87	turkey	turkey	PROPN
aiua-5031	151	88	sarikaya_stesura	sarikaya_stesura	PROPN
aiua-5031	151	89	seveso	seveso	VERB
aiua-5031	151	90	15/01/15	15/01/15	PROPN
aiua-5031	151	91	13:20	13:20	NUM
aiua-5031	151	92	pagina	pagina	NOUN
aiua-5031	151	93	290	290	NUM